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The twin-arginine translocase allows the translocation of folded protein substrates 
across the cytoplasmic membrane of bacteria and archaea or the thylakoid membrane of 
plants. In Escherichia coli, its protein components TatA, TatB and TatC assemble 
dynamically upon interaction with protein substrates. Prior to export, the machinery 
performs a quality control check so that only correctly folded proteins are translocated. 
The first objective of this work was to derive and apply new methodologies based on the 
inherent qualities of the pathway.      
We developed a new bacterial two-hybrid system that capitalizes on the folding 
quality control mechanism of the Tat pathway. One protein (prey) is fused to Tat-specific 
signal peptide.   A second (bait) protein is produced as a fusion to a reporter that produces 
 vi
a “signal” (growth or enzymatic activity) only when the bait-reporter fusion binds to the 
prey and the resulting complex is exported into the periplasm via the Tat pathway. 
As a second biotechnological application of the Tat pathway, we developed a 
phage display system that allows the protein of interest to fold within the cytoplasm prior 
export and display onto phage particles.  This is in contrast to the conventional phage 
display system, in which displayed protein folds in the periplasm. We took advantage of 
this new system to screen a library of 2 x 106 of fluorescent GFP variants containing a 
hexameric peptide insertion for ligand binding. Despite the diversity of the hexamer, we 
were not able to isolate single GFP variants that would bind with specificity to various 
ligands. This highlights the difficulty in engineering GFP variants that can bind to other 
proteins while retaining the ability to fluoresce.   
The second aspect of this research was to examine mechanistic aspects of the Tat 
pathway. TatB and TatC are responsible for the recognition of Tat signal peptides. Here, 
we established the importance of TatC as the crucial component of the Tat pathway for 
the interaction with the hallmark twin-arginine motif within Tat signal peptide.  
Substitution of the RR dipeptide with a KK sequence completely abolishes export. In a 
genetic screen using a ssTorA(KK)-GFP-SsrA as a reporter. We identified several amino 
acid substitutions within TatC that allowed the alteration of the substrate specificity of 
the pathway as indicated by the impairment of indigenous Tat substrates. Finally, we 
analyzed the conformational dynamics of TatA using GFP fusions and by incorporation 
of the chemically reactive, non-canonical amino acid azidohomoalanine.  
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Chapter 1 
 Protein translocation: molecular basis and biotechnological 
applications  
 
1.1 INTRODUCTION  
 
Every living organism contains a protecting lipid bilayer as a membrane which 
separates itself from the environment. One theory is that life could not have developed 
without the spontaneous self-organization of lipids and amphiphiles into supramolecular 
structures such as micelles and lipid-bilayers (Paleos et al. 2004). In living cells today, 
biological membranes have several roles. They are involved in compartmentalization and 
energy transduction, nutrition and ion transport, signal transduction and membrane-bound 
enzyme-catalyzed metabolic reactions. 
 
1.2 ENERGY SUPPLY FOR PROTEIN TRANSLOCATION 
 
Proteins are charged, bulky heteropolymers of which transport across or insertion 
into the low dielectric barrier of a membrane is thermodynamically highly unfavorable. 
Hence, there are several different transport pathways coupling the metabolic energy 
supplies to these processes to overcome this physical barrier. Most translocases utilize 
energy generated by the hydrolysis of nucleoside triphosphates, e.g. ATP or GTP. 
However, there are several different transport processes across biological membranes 
which solely rely on existing ion gradients. 
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In general, protein translocation can be summarized as a basic set of rules (Schatz 
and Dobberstein 1996). A precursor protein containing a targeting sequence which is 
typically N-terminal, is maintained in an unfolded state prior to export. This unfolded, 
export-competent state of the precursor protein is either achieved by cytoplasmic 
chaperones (post-translational) or by pausing translation followed by an immediate 
association of the protein-synthesizing ribosome with a receptor in the membrane (co-
translational export). The actual protein translocation is typically mediated by a set of 
transmembrane proteins which form a hydrophilic channel.  
 
 
1.2.1 The role of NTP in protein translocation 
Nucleoside triphosphate (NTP) hydrolyzing protein machineries typically 
contribute the majority of the driving force for protein transport. NTP driven mechanisms 
are differentiated based on which side of the membrane they are active: cis (pushing 
force) or trans (pulling force). An example for a cis active motor is the bacterial SecA 
protein which utilizes ATP for the threading around 25 amino acid in an unfolded state 
through the membrane (van der Wolk et al. 1997). An example for a trans-acting protein 
is the chaperone Hsp70 in eukaryotic cells which facilitates transport into the 
endoplasmatic reticulum (ER) or the mitochondrial matrix. In general, the mechanism of 
action can be described as a processive moving-along the unfolded polypeptide chain. 
Energy derived from NTP hydrolysis results in pulling or pushing of the polypeptide 
chain thus facilitating transport.  
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1.2.2 Proton motive force 
In addition to the energy derived from ATP or GTP hydrolysis cycles, most 
protein transport systems also use energy provided by the electrochemical gradient across 
the membrane. We are only starting to understand how the different transport systems 
adapt the electrochemical gradient into a driving force at a molecular level. For example, 
the energy stored in the mitochondrial inner membrane potential is absolutely necessary 
for the transport of matrix-targeted proteins even though the import machinery also 
involves Hsp70 and the use of ATP hydrolysis. This phenomenon applies similarly to the 
Sec machinery. The presence of the protein motive force (PMF) drives the translocation 
through the Sec pore once the polypeptide has been released from SecA. Further, the 
PMF prevents the backward slipping of the substrate (Schiebel et al. 1991; Driessen 
1992). However, at least for the Sec pathway, the PMF cannot initiate translocation 
(Driessen 1992). 
Energy stored in the proton motive force has two components: the electrical field 
gradient (Δψ) and the pH gradient (ΔpH). The proton gradient is generated by the free 
energy supplied by a downhill electron transfer chain. The electron transport chain 
catalyzes the oxidation of certain donor substrates e.g. NADH by certain acceptor 
substrates e.g. oxygen and couples this reaction to proton translocation across the 
membrane. Typically, at least two topological separate enzymes are required, a 
dehydrogenase and a reductase. The two are coupled functionally to a quinone that 
diffuses freely through the membrane. The dehydrogenase catalyzes the reduction of the 
quinone by the donor substrate whereas reoxidation of the quinol is catalyzed by the 
reductase which transfers electrons to an appropriate substrate. Protons translocated 
across the membrane establish the electrochemical gradient, which the cell uses mainly 
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for the generation of ATP via the ATP synthase, the establishment of ion gradients (Δψ), 
motility via flagella and directly or indirectly for protein translocation. 
 
1.2.3 Breaking the rules 
 About 10 years ago, a remarkable pathway was discovered that exports proteins 
in a fundamentally different manner (Berks 1996). Protein transport via the Twin-
Arginine Translocon (Tat) or the thylakoid ΔpH import pathway of plants does not follow 
the general sets of rules for protein translocation described in the section above. The Tat 
pathway solely relies on the membrane potential to export folded proteins across the 
cytoplasmic membrane. No NTP hydrolysis or cis-acting chaperones have been identified 
(Robinson and Bolhuis 2001). The precise role of the membrane gradient is unknown. 
For E. coli, the ΔpH is not required; however, Δψ is essential to drive Tat-mediated 
tanslocation (Bageshwar and Musser 2007). 
 
1.3 PROTEIN TRANSPORT IN BACTERIA 
 
All bacteria have a cytoplasm which is surrounded by a lipid-bilayer. In addition, 
Gram-positive bacteria are protected by a thick peptidoglycan layer whereas Gram-
negative bacteria have a much thinner and differently structured peptidoglycan layer as 
well as an extra outer membrane, formed by an asymmetric lipid-bilayer. The space 
between the cytoplasmic membrane and the outer membrane is called the periplasm.  
 
 
Figure 1.1.  Overview of a Gram-negative bacterium and location choices for newly 
synthesized proteins. Indicated are the inner and outer membrane of the 
bacterium; the peptidoglycan layer which is located in the intermembrane 
space, has been omitted for simplicity.In orange arrows indicate the 
different routes a protein can follow. 
 
In Gram-negative bacteria, a nascent protein exiting the ribosome can follow 
several different routes and end up at different final destinations. If the protein is not 
destined for the cytoplasm, it can be targeted into either the inner or the outer membrane, 
or across one or both membranes where it can localize in the periplasmic space or in the 
extracellular space respectively.  
 
1.4 TRANSPORT SYSTEMS IN THE CYTOPLASMIC MEMBRANE  
 
In gamma proteobacteria, the main route for protein transport across the 
cytoplasmic membrane is through the Sec translocon which is the bacterial homologue to 
the Sec61 in eukaryotic cells. From the perspective of the translocated protein, the main 
difference between the Sec and Tat translocation is the location of its folding maturation. 
For Sec substrates, folding and co-factor assembly occurs in the periplasm. Folding is 
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assisted by periplasmic chaperones such as DegP which functions as either protease or 
chaperone depending on the temperature, Skp, and four peptidyl-proline cis-trans 
isomerases, PpiA, PpiD, SurA and FkpA. The periplasm is an oxidizing environment 
mainly due to the action of DsbA which oxidizes free cysteines, whereas the isomerase 
DsbC rearranges disulfide bridges to their native conformation (Georgiou and Segatori 
2005).  
In contrast, Tat proteins fold within the cytoplasm.  The cytoplasmic folding 
environment contains the general chaperones GroEL, DnaK/DnaJ/GrpE, the trigger 
factor, ClpB and the small heat-shock chaperones (IbpAB) (de Marco 2007) among 
others. Further for the incorporation of some cofactors, whole maturation pathways 
involving several enzymes are necessary. For example the incorporation of iron-sulfur 








Figure 1.2. Protein export across the cytoplasmic membrane. The Sec pathway 
sequentially threads its substrates through the Sec pore and assembly occurs 
in the periplasmic environment whereas the Tat pathway only exports its 






1.4.1 The Sec pathway 
 
The Sec apparatus transports its substrates in an unfolded state through a narrow 
pore minimally established by SecYEG. Translocation can occur in two different 
manners which have been referred to as the co-translational and the post-translational 
export mode.  Co-translational export involves the signal recognition particle (SRP) 
which is composed of the protein Ffh (fifty four homologue, based on its similarity to the 
eukaryotic SRP version in the endoplasmatic reticulum) and a 4.5S RNA unit (Luirink et 
al. 1992). The co-translational mode is often also referred to as the SRP pathway; it is 
ubiquitously found in all three kingdoms of life, however, E. coli operates the simplest 
version.  
SRP binds to the signal peptide or a highly hydrophobic peptide stretch that exits 
the ribosome as a nascent polypeptide chain (Kim et al. 2001) (Fig.1.3.A). The loaded 
SRP complex binds to the membrane-bound receptor FtsY which mediates the interaction 
of Ffh with the Sec translocon (Fig.1.3.B); GTP hydrolysis is necessary to release the 
signal peptide or a hydrophobic patch in case of a membrane domain, which allows the 
handing-over of the substrate to the Sec translocon. The ribosome is recruited to the 
membrane where the rest of the polypeptide is directly synthesized (see Figure 1.3.C).  
Proteins following the co-translocational export route are typically inner membrane 
proteins.  There is only one known exception in E. coli in which a non-membrane protein 
is exported via the SRP pathway: DsbA. DsbA probably folds to rapidly to be maintained 
in an unfolded state which is required for post-translational Sec transport(Schierle et al. 
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2003). It is conceivable that the co-translational route could be utilized for any protein 
which is otherwise prone to aggregation in the cytoplasm.  
The post-translational mode involves the tetrameric chaperone SecB which binds 
to a nascent chain exiting the ribosome to prevent its immediate folding (Fig.1.3.E). In 
SecB mutants other general chaperones such as GroEL and/or DnaK can compensate for 
the loss of SecB (Kumamoto 1991). The association with SecB maintains the protein in a 
transport-compatible state since only the unfolded protein can be threaded through the 
membrane. SecB typically transfers its substrate directly to SecA. SecB binds dimeric 
SecA in an asymmetric fashion which presumably allows the dissociation of one SecA 
monomer, introducing a conformational change within SecA (Randall et al. 2005). A 
partial dissociation may allow the transfer step of the precursor protein to SecA. SecB 
eventually releases the precursor since it is not necessary for the translocation event 
(Fekkes et al. 1997). The translocation through the Sec pore is a step-wise event in which 
ATP hydrolysis by SecA allows the threading of around 20-30 amino acids of the 
polypeptide through the membrane (van der Wolk et al. 1997), (Figure 1.3.F).  
 
1.4.2 The YidC pathway 
 
YidC is a 60 kD transmembrane protein of E coli, which is essential for the 
survival of the cell. It is localized in the inner membrane and is the only export 
machinery that has been conserved in the inner membrane of mitochondria throughout 
evolution. It functions as a membrane protein integrase (Samuelson et al. 2000). In 
bacteria, it can either operate independently or associate with the SecDFYajC proteins of 
the Sec pathway assisting the lateral integration of transmembrane domains into the lipid 
bilayer (Economou and Wickner 1994). The YidC-assisted lateral transfer of the 
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hydrophobic domains of  transmembrane α-helices  into the bilayer prevents the Sec 
translocon from jamming (Luirink et al. 2005) (Figure 1.3.G). Only a few protein 
substrates that follow the Sec-independent mode of the YidC pathway have been 
identified (Figure 1.3.H). These are simple inner membrane proteins (IMPs), including 
the small phage coat proteins M13 and Pf3, and the endogenous IMPs Foc of the ATP 
synthase (Facey and Kuhn 2004).  
Recently, a third mode for a YidC dependent transport was discovered. The 
mechano-sensitive channel protein MscL is integrated into the inner membrane via YidC 
in a Sec-independent manner. In the case of MscL, the SRP promotes its membrane 
targeting via the FtsY receptor. Once associated with the membrane, MscL is integrated 






Figure 1.3. Overview of Sec- and YidC-mediated protein translocation. 
 
1.4.3 The Tat pathway  
Unlike the Sec pathway, the Twin-Arginine Transporter pathway exports proteins 
in a folded state through the cytoplasmic membrane. The minimal composition of the Tat 
translocon consists of the protein components TatA, TatB and TatC (Figure 1.4). TatB is 
dispensable in some Gram-positive bacteria or can replaced by  mutated TatA variants 
(Blaudeck et al. 2005).  In early studies, TatE, which is 50% identical to TatA, was 
thought to be an essential component of the translocon. However, TatE is not localized 
within the tat  operon, it is 50-100 times less expressed than TatA (Jack et al. 2001) and 
its deletion has no impact on the export of model protein substrates (Sargent et al. 1998). 
Hence, all functional Tat components are encoded within the tat operon (tatA,B,C,D) 
which also contains TatD, a protein containing DNAse activity which is not involved in 









1.5 THE TAT  PATHWAY  
The Tat pathway was discovered in bacteria around 10 years ago (Berks 1996), 
and in the thylakoids membrane of plants  15 years ago (Cline et al. 1992). Little is 
known about the detailed mechanism of protein translocation via the Tat pore. The most 
remarkable feature of the Tat pathway is that it exports completely folded and assembled 
substrates that are monitored for correctness of folding by an inherent proof-reading 
mechanism (DeLisa et al. 2003). The pathway solely operates on a proton motive force 
(Alder and Theg 2003; Bageshwar and Musser 2007) and so far no ATP requirement was 
demonstrated. The Tat pathway is highly conserved in archaea, in most bacteria and in 
the chloroplasts of plants. However it is not presereved in the mitochondria of most 
eukaryotes. Only a few protozoa encode Tat components in their mitochondrial genome. 
For example, the protist of Jakobis family Reclinomonas americana has the largest and 
eubacteria-like mitochondrial genome known to date (Lang et al. 1997). This organism 
carries next to a TatC homologue a TatA homologue in its mitochondrial genome (Gray 
et al. 2004).  
 
1.5.1 Tat components  
1.5.1.1 TatA 
TatA is the most abundant component of the Tat export apparatus and it is 
believed to mediate the actual translocation step. Originally, TatA was postulated to 
contain one transmembrane domain with its N-terminal end facing the periplasmic side of 
the cytoplasmic membrane, and a second amphipathic helix located within the cytoplasm, 
but associated with the lipid bilayer (Porcelli et al. 2002). TatA forms both in vivo as well 
as when solubilized in detergent oligomeric complexes. When surveying purified TatA,   
asymmetric pore-like formations with lid-like structures can be detected by single particle 





Figure 1.5. Single particle electron microscopy of purified TatA in detergent. The size 
and the pore-like formation indicated that these oligomers might 
accommodate transport of Tat substrates. Class 10 oligomers contain about 
30 TatA oligomers and are 15 nm in width with a possible 8 nm diameter for 
a pore. Adopted from (Gohlke et al. 2005) Copyright © Proc. Natl. Acad. 
Sci. USA  
Two independent topology studies claim two different orientations of TatA, but 
both were in agreement about a dual topology of the amphipathic helix of TatA.   
When the C-terminal end of TatA was fused to the periplasmic reporter alkaline 
phosphatase (AP), AP activity was demonstrated suggesting a periplasmic location for 
the C-terminus. On the other hand, fusion of TatA to the cytoplasmic reporter β-
glucuronidase (UidA) indicated a cytoplasmic location for the C-terminus. This evidence 
points towards a possible dual-topology of TatA with its N-terminal end facing the 
periplamic site but with an ambiguous location of the amphipathic helix which can be 
either periplamic or cytoplasmic (Gouffi et al. 2004)( see Figure 1.6.A).  
 Chan and co-workers (Chan et al. 2007) proposed an alternative model for the 
topology of TatA that contradicted the above studies (Figure 1.6.B). Utilizing a 
membrane permeable and a non-permeable thiol-reactive agent, they demonstrated that a 
cysteine residue introduced within the N-terminus at position 2 reacted only with the 
membrane permeable probe indicating a cytoplasmic localization of the N-terminus. A 
cysteine residue introduced at the C-terminal end of the transmembrane domain on the 
other hand was labeled by the impermeable probe, indicating accessibility from the 
periplasmic site (Chan et al. 2007).  Further, they claimed that the amphiphatic helix can 
be found either within the membrane or within the cytoplasm when using the same 




Figure 1.6. Models for the dual topology of TatA. The dual topology of the C-terminus 
has been confirmed by several different studies. The location of the N-
terminus remains controversial. 
 
 1.5.1.2 TatB 
The protein TatB is the least-studied component of the Tat machinery. For E. coli, 
and most other Eubacteria and Archaea, TatB is an essential component of the Tat 
translocon (Bogsch et al. 1998). However, a few Gram-positive organisms do not encode 
any TatB homologues. Hence, it has been proposed that TatA might have a bi-functional 
role when TatB is missing (Blaudeck et al. 2005; Barrett et al. 2007). A further possibility 
is that only certain substrates require TatB for translocation.  Even in E. coli, a few 
substrates such as the reporter protein MBP, can be exported via Tat without TatB, 
indicating a possible redundancy in the translocation event. It was also hypothesized that 
TatB might have a specific role in the inherent proof-reading mechanism of the Tat 
pathway which has not been confirmed yet (Fisher and DeLisa 2004). 
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TatB is 25% identical with TatA at the amino acid level and seems to have a 
similar topology as TatA, containing one transmembrane domain and one amphipathic 
helix,. The N-terminus of TatB forms the transmembrane domain, whereas the C-
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terminus is aligned with the membrane on the cytoplasmic site. When the transmembrane 
domain of TatB is removed, the ampipathic helix is still associated with the membrane 
whereas the amphiphatic helix of TatA can only be found in the soluble fraction (De 
Leeuw et al. 2001). Truncation analyses demonstrated that only the first 101 N-terminal 
amino acids of TatB are necessary for function (Lee et al. 2002). TatB associates with 
TatC in an equimolar ratio in complexes of around 400 – 550 kD  (McDevitt et al. 2006). 
As mentioned below the TatB/TatC complex is responsible for signal peptide recognition. 
TatB and TatC within the receptor complex exhibit distinct types of interaction with the 
signal peptide: TatC  interacts with the twin-arginine motif (Alami et al. 2003; 
Kreutzenbeck et al. 2007b; Strauch and Georgiou 2007b) whereas TatB seems to interact 
with the hydrophobic part of the signal peptide (Alami et al. 2003).  
 
1.5.1.3 TatC 
TatC is the most conserved component of the Tat pathway. It has 6 
transmembrane domains in E. coli with both the C- and N-terminus facing the 
cytoplasmic side of the inner membrane (Buchanan et al. 2002; Ki et al. 2004). It 
establishes, together with TatB, the signal receptor complex which specifically 
recognizes the twin-arginine motif (Kreutzenbeck et al. 2007b; Strauch and Georgiou 
2007b). The function of TatC is discussed in detail in chapter 3. 
 
1.5.2 Tat substrates and alternative respiration   
 
As with most bacteria, E. coli has the ability to adapt to a number of different 
environments.  Its natural environment is the mammalian intestine where it assists waste 
processing and the production of vitamin K. It contains several anaerobic respiratory 
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chains allowing the usage of different final electron acceptors. As described above, each 
respiratory chain has common components: a dehydrogenase or oxidase that allows the 
transfer of electrons from a substrate to the quinone pool, and a reductase that accepts 
electrons from the quinone pool and transfers them to a terminal electron acceptor.  E. 
coli is capable of using oxygen as a terminal electron acceptor, but in anoxic 
environments is  can utilize nitrate, nitrite, fumarate, trimethylamine-N-oxide (TMAO), 
or dimethyl sulphoxide (DMSO) as terminal electron acceptors.  Most substrates of the 
Tat pathway are involved in various anaerobic respiratory chains. One of the few Tat 
substrates for which the structure has been solved is formate dehydrogenase (Jormakka et 
al. 2002). The molecular dimensions of formate dehydrogenase span up to 8 nm in width 
and over 15 nm in length (Figure 1.7). The enzyme is believed to form a trimeric unit 
once it is anchored into the cytoplasmic membrane. It is difficult to imagine how a 
completely folded protein of this size can cross the cytoplasmic membrane without 
forcing the the membrane potential to collapse. Since most substrates of the Tat pathway 
belong to anaerobic respiratory chains and catalyze redox reactions, they typically require 
a set of complex cofactors and often additional polypeptide subunits. The incorporation 
of these cofactors often requires specialized chaperones which are only available in the 
cytoplasm. For example trimethylamine N-oxide reductase (TorA) contains a FeS cluster 
and a bis-molybdopterin guanine dinucleotide (MGM) cofactor (Mejean et al. 1994). For 
the assembly process, TorA has its own chaperone, TorD, which greatly facilitates the 
incorporation of the cofactors and retards the export process (Pommier et al. 1998). TorD 
binds to the signal peptide and parts of the enzyme. 
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Since most of the Tat substrates function in anaerobic respiration, it is therefore 
surprising that the expression of the tat operon containing the tatA,B,C,D genes is 
constitutive (Jack et al. 2001). However, there are also several Tat substrates which are 
involved in other biological processes. As an example AmiA and AmiC are amidases 
which cleave the peptide moiety of the peptidoglycan layer, a step essential for the 
completion of cell division. It is the mislocalization of these enzymes which causes the 
chain-like formation of tat mutant cells. The Tat substrate cupper oxidase (CueO) a 
homologue of laccase confers higher resistance to Cu(II) (Tree et al. 2005) whereas its 
homologue SufI might contribute to a general robustness of the cell division apparatus in 
particular under conditions of stress  (Samaluru et al. 2007). Further examples of Tat 
substrates which are not involved in respiration include MdoD, an enzyme that is 
involved in  the synthesis of the osmoregulated periplasmic glucan backbone structures 
(Lequette et al. 2004) and WcaM, which is involved in lipopolysaccharide biosynthesis. 
In some pathogenic organisms, Tat substrates are virulence factors (see section on 




Figure 1.7. Crystal structure one unit of the timeric formate dehydrogenase (1KQF.pdb). 
Dimensions of this Tat substrate are indicated. FdnG containing the signal 
peptide is indicated in yellow, FdnH which presumably gets co-transported 
with FdnG does not contain a signal peptide (blue subunit). The 
corresponding cytochrome FdnI is colored in green.  
Table 1.1. E.coli Tat substrates 








HyaA Hydrogen oxidation 3×Fe-S clusters HyaB HyaE Tat 
HybO Hydrogen oxidation 3×Fe-S clusters HybC HybE Tat/Sec 
HybA Hydrogen oxidation 4×Fe-S clustersa Unknown Unknown Tat/Sec 
NapG Nitrate reduction 4×Fe-S clustersa Unknown Unknown Tat 
NrfC Nitrite reduction 4×Fe-S clustersa Unknown Unknown Tat 




YdhX Unknown 4×Fe-S clustersa Unknown Unknown Tat/Sec 
TorA TMAO reduction MGD None TorD Tat 
TorZ TMAO reduction MGD None YcdYa Tat/Sec 
NapA Nitrate reduction MGD, 1×Fe-S 
cluster 
None NapDa Tat 
DmsA DMSO reduction MGD, 1×Fe-S 
cluster 
DmsB DmsD Tat/Sec 
YnfE DMSO reduction MGD, 1×Fe-S 
clustera
YnfGb DmsDa Tat 
YnfF DMSO reduction MGD, 1×Fe-S 
clustera
YnfGb DmsDa Tat/Sec 
FdnG Formate oxidation MGD, 1×Fe-S 
cluster 
FdnH FdhDa, FdhEa Tat 
FdoG Formate oxidation MGD, 1×Fe-S 
clustera
FdoHb FdhDa, FdhEa Tat 
YedY TMAO/DMSO 
reduction 
MPT None Unknown Tat/Sec 
CueO Copper homeostasis 4×Cu ions None Unknown Tat/Sec 
SufI Possibly cell 
division 
None Unknown Unknown Tat/Sec 
YahJ Unknown 1×Fe iona Unknown Unknown Tat/Sec 
WcaM Colanic acid 
biosynthesis 
Unknown Unknown Unknown Tat 
MdoD Glucans 
biosynthesis 
Unknown Unknown Unknown Tat/Sec 
YcdB Unknown Unknown Unknown Unknown Tat/Sec 
AmiA Cell wall amidase None Unknown Unknown Tat/Sec 
AmiC Cell wall amidase None Unknown Unknown Tat/Sec 
FhuD Ferrichrome 
binding 
None Unknown Unknown Tat/Sec 
YcbK Unknown Unknown Unknown Unknown Tat 
 
list of known and predicted Escherichia coli Tat substrates (Palmer et al. 2005; Tullman-
Ercek et al. 2007), see note  
 
a Predictions inferred by homology, genetic linkage or sequence analysis; (Berks et al. 2003) and (Turner et 
al. 2004) for reviews.  
 
 
1.5.3 Signal peptides 
Most proteins which are exported across a membrane are synthesized as a precursor form 
with an N-terminal signal peptide. Signal peptides are evolutionarily well-conserved N-
terminal extensions. A signal peptide has three distinct regions (Figure 1.8). The N region 
harbors a positive charge whereas the hydrophobic H-region comprises the center and the 
longest part of the signal peptide. The H-region of Tat signal peptides has a less 
hydrophobic character and is typically longer than that of Sec signal peptides. The N-
terminal positively charged region of Tat signal peptides contains the hallmark twin-
arginine amino acids with the consensus sequence of S/T-R-R-x-F-x-K. The C-region of 
both Sec and Tat signal peptides bears the signal peptidase cleavage site which is 
recognized by the signal peptidase type I (Paetzel et al. 2002). In general, Tat signal 
peptides typically contain a lysine or arginine residue within this region which has been 
described as Sec avoidance sequence (Blaudeck et al. 2003). The more positively charged 
the C-region and beginning part of the mature protein is the higher the chance that the 
signal peptide will not be targeted to the Sec pathway (Tullman-Ercek et al. 2007).  
 
 
Figure 1.8. Signal peptides. Comparison between a Sec and Tat signal peptides. N, H and 
C region are indicated. The positive charge within the C region of a Tat 
signal peptide marks the Sec avoidance signal. 
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  NMR studies on the signal peptide of HiPIP, the high potential iron-sulfur protein 
(HiPIP) from Allochromatium vinosum which had been purified from inclusion bodies 
and refolded, indicate that the signal peptide is unfolded in solution (Kipping et al. 2003). 
The purpose of an exposed signal peptide could be to facilitate recognition by the 
translocation machinery. Different theories about the signal recognition process have 
been proposed. In one theory, the signal peptide associates with the membrane and scans 
along the lipid bilayer until it interacts with the receptor complex of the transporter. It is 
also possible that the signal peptide interacts directly with the receptor complex. Surface 
plasmon resonance studies of purified precursor proteins (ssTat-GFP) demonstrated 
electrostatic and hydrophobic interactions of the signal peptide with displayed 
phospholipids. This evidence implies an initial interaction of the signal peptide with the 
membrane before the it is recognized by the Tat translocon  (Shanmugham et al. 2006).  
 
1.5.3.1 Identification of new Tat substrates based on signal peptide analysis 
In a bioinformatics analysis study, the complete E. coli genome was searched for 
proteins containing a Tat consensus sequence within putative signal peptides.  This 
analysis identified 29 putative protein substrates. Signal peptides of all potential 
substrates were fused to the reporter proteins maltose binding protein (MBP), alkaline 
phosphatase (AP) and green fluorescence protein (GFP) (see section 1.6.3 under “reporter 
constructs”) and tested for their functionality. Only 11 signal peptides were found to be 
strictly Tat-dependent whereas the remaining 18 are were shown to be promiscuous, 
allowing export through either Sec or Tat pathway (Tullman-Ercek et al. 2007). It seems 
reasonable that the cell throughout evolution maintained flexibility in the translocation of 
certain enzymes to ensure their correct localization even under conditions in which the 
Tat export pathway was compromised.  
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1.5.4 Translocation model 
The current model for Tat translocation is based on biochemical data from co-
purification, in vitro reconstitution,  immunoprecipitation and electron microscopy  
(Gohlke et al. 2005).  In addition, cross-linking studies (Alami et al. 2003) including 
cysteine cross-linking (Lee et al. 2006; Greene et al. 2007; Punginelli et al. 2007) and 
genetic analyses (Kreutzenbeck et al. 2007a; Strauch and Georgiou 2007b) have been 
employed to elucidate the molecular basis of Tat export. In E. coli, three proteins TatA, 
TatB and TatC are essential for the formation of a functional translocon. In resting 
membranes, TatA, TatB and TatC can be isolated as a 600 kD complex (Bolhuis et al. 
2001; de Leeuw et al. 2002). TatA can be pulled out of the membrane as high-molecular 
weight complexes of varying sizes whereas TatB and TatC tend to co-purify with each 
other in a stoichiometric manner. Overexpressed, TatB/TatC complexes typically contain 
variable amounts of TatA oligomers (Bolhuis et al. 2001; de Leeuw et al. 2002). 
However, more recently it was demonstrated that more moderate expression levels of the 
translocon components results in two distinct types of complexes in which one comprises 
only TatB/TatC oligomers and a second complex is established by TatA oligomers 
(Orriss et al. 2007). Hence, both complexes are stable without each other. This 
contradicts an earlier theory in which it was postulated that the TatB/TatC subcomplex 
could only be found in the presence of TatA oligomers due to its instability (Mangels et 
al. 2005).  
The re-adjustment of the composition of the core complexes of the E. coli Tat 
machinery resembles the plant ΔpH pathway. So far, the plant TatA homologue Tha4 was 
only found associated with the TatB homologue Hcf106 and cpTatC version when the 
translocon was active (Cline and Mori 2001). For the plant TatA homologue, it was 
demonstrated that the aspartate residue in the transmembrane domain is crucial for the 
recruitment of more TatA oligomers. Cline et al. proposed that substrates first bind to the 
TatB/TatC receptor complex and are then handed-over to the pore- forming TatA 
complex. This transfer step is postulated to initiate the final translocation step mediated 
by TatA oligomers.  In the bacterial TatA, there is no aspartate in the N-terminal region, 
however an aspartate can be found at the N-terminus of TatB. Hence, there might be 
differences in the mode of TatA recruitment between the thylakoid and the bacterial 
pathway. The model of a “handing-over” mechanism of the substrate to recruited TatA 
oligomers might be only partially true since export can still occur when the signal peptide 
is fused to the C-terminus of the plant TatC homologue (Gerard and Cline 2006). This 
finding implies that the role of the signal peptide recognition is an independent step from 
the translocation step. However, the division of the translocation step into two separate 
events is reflected in the biophysical properties of  the translocation: Bageshwar and 
coworkers demonstrated that translocation requires two electric potentials to take place 
(Bageshwar and Musser 2007). Therefore it is reasonable to assume that translocation 






Figure 1.9. Current translocation model. TatB and TatC establish the signal peptide 
recognition complex. Upon interaction with the signal peptide of the 
precursor protein, a possible conformational change occurs which signals 
binding,  followed by the recruitment of several TatA oligomers. TatA 
oligomers assemble in complexes of variable sizes which might depend on 
the dimensions of the substrate. TatA putatively mediates the actual 
translocation event.  
 
The role of TatB and TatC functioning as a receptor complex in bacteria was first 
shown by in vitro cross-linking studies. TatC was found cross-linked to the twin-arginine 
consensus motif whereas TatB was found to associate with the hydrophobic part of the 
signal peptide at a later step. Genetic screens by Kreuzenberg (Kreutzenbeck et al. 
2007b) and research described in the third chapter of this document confirm the role of 
TatC as a the site for the initial interaction site of the twin-arginine part of the signal 
peptide.  
 
1.5.5 Folding quality control  
Knowing that the Tat pathway exports folded proteins, provokes the question 
whether there is a relationship between folding quality and export competence. Does the 
pathway discriminate between folded and unfolded proteins?  
In an elegant study DeLisa and coworkers showed that alkaline phosphatase, in 
which two intermolecular disulfide bridges must form for it to assume its active dimer 
conformation, cannot be exported when expressed in cells with a reducing cytoplasm that 
prevents disulfide bond formation. The same was found to be true for a FAB antibody 
fragment. A FAB antibody fragment is a heterodimeric protein in which the heavy chain 
(VH-CHL) and light chain (VL-CL) are linked by an intermolecular disulfide bond; in 
addition it contains four more intrachain disulfides, two within each of the heavy and 
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light chains. However, this export deficiency could be eliminated once disulfide bridge 
formation was allowed in the cytoplasm (DeLisa et al. 2003). The deletions of gor and 
trxB in the strain FA113 (MC1000 phoR ΔphoA,PvuIIΔ(malF)3 trxB gor552 Tn10tetr 
ahpC*, F'[lacIq ZYA pro]) inactivate the thioredoxin and the glutathione reduction 
pathways which normally maintain the cytoplasm under reducing conditions. Without the 
reducing power of these two pathways, oxidation can take place in the cytoplasm 
probably due to  Fenton reactions (Bessette et al. 1999). Similarly, Fisher and coworkers 
showed that maltose binding protein variants (MBP-G32D, MBP-I33P, and MalE31 
(G32D/I33P)), which are prone to aggregation of off-pathway folding intermediates, were 
incompetent for export. The export rate was directly correlated with their folding ability  
(Fisher et al. 2006).  This phenomenon indicates that the pathway functions as a filter for 
the folding ability of a protein. Based on these observations, Richter and coworkers 
hypothesized that it might be the exposure of hydrophobic patches which allows the 
pathway to determine whether a protein is folded or misfolded (Richter et al. 2007).  
Richter et al. studied the  yeast nuclear pore protein Nsp1p which contains a domain with 
polar FG-repeats which is maintained in a naturally unfolded conformation (Denning et 
al. 2003). These multiple repeats of 19 amino acids are unstructured and constitute a 
flexible peptide region which is important for the transport through the nuclear pore. 
When promoting export of different sized peptide variants of these FG repeats through 
the Tat pathway, translocation could be demonstrated despite their unfolded nature. 
However, no export was observed when short hydrophobic stretches were integrated into 
the FG-repeats. This evidence demonstrates that export competency is not based on the 
type of fold (unstructured or structured), but is rather simply based on the accessibility of 
hydrophobic regions on the outside of the protein. Hence, it is conceivable that the 
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protein quality control of Tat is based on the discrimination of surface-exposed 
hydrophobic patches, not their folds. 
 
 
1.5.4 Signal peptide specific chaperones 
Several cofactor-containing Tat substrates have their own dedicated chaperone. 
For example, TorD which assists the maturation of TorA, binds specifically to the TorA 
signal peptide and also weakly to parts of the mature protein preventing premature 
export. Its function is to shield the mature TorA protein from recognition by the Tat 
translocon providing time for the assembly process (Hatzixanthis et al. 2005). TorD binds 
with specificity to the core region of the TorA signal peptide. The binding step is 
independent of the presence of the twin-arginine motif, since its affinity for the signal 
peptide is not reduced by exchanging the twin-arginine for the non-functional twin-lysine 
motif. Once TorD is bound to the signal peptide, its affinity for GTP increases. However 
the precise role of GTP in the chaperone function has not been elucidated. It should be 
noted that there are many protein–protein interactions mediated by GTP binding proteins 
such as the eukaryotic G protein systems in which guanosine nucleotide exchange factors 
are required to activate G proteins. Whether there is a similarity between the mode of 
protein interaction of TorD to the mode of interactions of G proteins has yet to be 
revealed.  
Similarly to TorA, DMSO reductase DmsA and nitrate reductase NarG contain a 
molybdenum cofactor and an iron-sulfur cluster. Their folding maturation is assisted by 
the small chaperones DmsD and NarJ, respectively (Oresnik et al. 2001; Chan et al. 
2006). Not surprisingly, several of these chaperones are phylogenetically related. Based 
on phylogenetic analyses, TorD and NarJ have been classified as one group of maturation 
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chaperones, whereas DmsD and  NapD, which assists the folding of the nitrate reductase 
NapA (Maillard et al. 2007) have been assigned to a second group. At least for NapD, it 
was recently demonstrated that its molecular role is not only to camouflage the signal 
peptide; it  actively inhibits the transport event before it determines whether the folding 
maturation is completed   (Maillard et al. 2007). As a third group for Tat chaperones, the 
small chaperones HyaE and HybE were pulled out of protein-protein interaction screens; 
they assist in the folding maturation of  [NiFe] containing  hydrogenase 1 (HyaA) and 
hydrogenase 2 (HybO/HybC), respectively (Dubini and Sargent 2003).   
In respect to the proof-reading mechanism of the Tat pathway it is reasonable that 
this function is divided into two distinct events, one taking place before the interaction 
with the translocon and performed by the signal peptide-specific chaperone which (a) 
prevents export before maturation and (b) assists folding, whereas the second part of the 
quality control is undertaken by the twin-arginine translocon itself, which discriminates 
against proteins with exposed hydrophobic regions.  
  
1.6 PROTEIN EXPORT REPORTER SYSTEMS FOR MONTORING TAT EXPORT 
1.6.1 Disulfide bridge formation  
Disulfide bond formation is important for the correct folding and stability of many 
periplasmic proteins. In E. coli, disulfide bridges of proteins are formed in the 
periplasmic space of the bacterium.  
The periplasmic protein DsbA and the integral membrane protein DsbB catalyze 
the oxidation of cysteine residues in proteins. However, the DsbA/DsbB mediated 
oxidation acts unspecifically, with DsbA immediately oxidizing consecutive cysteine 
residues as the protein exits the Sec pore and enters into the periplasmic space (Berkmen 
et al. 2005). Proof-reading and correction of disulfide bond formation is performed by the 
DsbC/DsbD system (Berkmen et al. 2005). DsbC functions as  a disulfide isomerase, 
which re-arranges non-native disulfides to their native configuration. RNase I, MepA 
(Hiniker and Bardwell 2004), acid phosphatase (AppA) (Berkmen et al. 2005) and the 
heterologous protein human tissue-type plasminogen activator (tPA) (Qiu et al. 1998) 
depend on DsbC for folding. DsbC is maintained in a reduced state by its interaction with 
the integral membrane protein DsbD, which on the other hand receives electrons through 
its interaction with cytoplasmic thioredoxin. Oxidized thioredoxin is recycled by 
thioredoxin reductase which uses the NADPH pool as electron source (Collet and 
Bardwell 2002), see Fig.1.10. 





The first step in the formation of disulfide bridges is catalyzed by the 21 kDa 
enzyme DsbA. Recent studies by Berkman and Beckwith (2005) concluded that this step 
predominantly takes place while the substrate is being translocated by the Sec-pathway 
through the cytoplasmic membrane (Berkmen et al. 2005). The active site of DsbA 
contains a Cys30–Cys33 disulfide bond which has a redox potential of −120 mV and 
therefore it is a potent oxidant (Rietsch et al. 1997). The formation of a disulfide bridge is 
initiated by the formation of an unstable mixed disulfide between DsbA and the target 
protein. The transient complex is then attacked by another thiol-group of the target 
protein, and reduced DsbA is released. DsbA is subsequently re-oxidized by the action of 
the inner membrane protein DsbB. DsbB transfers its electrons onto oxidized ubiquinone 
with oxygen as a final recipient mediated by cytochrome oxidases under aerobic 
conditions (Figure 1.10). Under anaerobic conditions, DsbB passes electrons to the 
menaquinone pool in the cytoplasmic membrane which transfers the received electrons 
onto another reductase e.g. fumarate reductase or nitrate reductase (Collet and Bardwell 
2002). Since: (i) the function of DsbA is dependent on its subcellular localization  and (ii) 
its activity can be easily measured by determining the formation of active alkaline 
phosphatase,  DsbA is a useful reporter for detecting  the localization of a fusion protein 
exported either via the Sec (Huber et al. 2005a) or the Tat pathway (see second chapter). 
 
1.6.1.2 Alkaline phosphatase 
One of the substrates of DsbA is alkaline phosphatase (AP) encoded by the gene 
phoA (Chang et al. 1986; Akiyama and Ito 1993). AP is a periplasmic enzyme of E. coli, 
exported via the Sec pathway in a post-translational manner. It contains zinc and 
magnesium as cofactors in its homodimeric form in which each subunit is stabilized by 
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two intramolecular disulfide bridges. AP cleaves phosphate from a broad range of 
substrates. The phoA gene is part of the pho regulon, which is controlled by a two-
component regulatory system established by PhoR (sensor kinase) and PhoB (the 
transcriptional activator protein). At least 30 different genes have been reported to be part 
of this regulatory network. Under phosphate starvation conditions, the sensor kinase 
PhoR phosphorylates itself (forming PhoR-P). The phosphate starvation signal is then 
delivered by the transfer of the phosphate group onto dephosphorylated PhoB, which in 
turn activates the expression of all genes within the pho regulon. Hence, low phosphate 
concentrations activate transcription from the phoA promoter (Martin 2004). 
AP is synthesized with an N-terminal 20 amino acid long Sec- signal peptide that 
is removed during translocation across the cytoplasmic membrane.  Following export its 
free cysteines residues are immediately oxidized by DsbA (Berkmen et al. 2005). AP has 
been used as a reporter  for disulfide bridge formation,  for Sec-dependent export, and for 
periplasmic localization (Manoil et al. 1990). More recently it was used as a reporter for 
Tat-dependent export in cells with oxidizing cytoplasm (DeLisa, Tullman et al. 2003). 
 
 
1.6.2 Maltose binding protein 
Maltose binding protein belongs to a class of proteins described as periplasmic 
binding proteins (PBPs) which represents a large family of receptor proteins that 
recognizes a variety of small molecule ligands within the periplasm. These receptors are 
involved in carbon catabolism, amino acid and iron transport, chemotaxis and quorum 
sensing (Tam and Saier 1993). Transport mediated by PBPs typically involves an ABC 
transport system in which ATP hydrolysis mediates the transport process of the ligand.  
 MBP, encoded by the gene malE, is part of the maltose system that is responsible 
for the recognition and uptake of α(1→4)-linked glucose polymers (maltodextrins) up to 
7 to 8 glucose units (Boos and Shuman 1998). Both substrate-loaded and substrate-free 
conformation of MBP can bind the integral membrane proteins MalF and MalG which 
establish the channel. However, an enormous conformational change occurs within MBP 
upon substrate binding: its two free lobes close up over its substrate upon binding and 
only this conformational re-arrangement allows MBP to initiate the transport cycle. ATP 
can bind to two copies of MalK, which is aligned to the cytoplasmic side of the channel. 
This binding step coincides with a simultaneous opening of both MBP and the 
periplasmic entrance of the translocation pathway (Austermuhle et al. 2004), channeling 
maltose inside the cell (Figure 1.11).  
 
 




The requirement for MBP for the catabolism of maltose as a carbon source has 
been exploited in simple genetic selections for growth on maltose minimal media plates 
or for screening assays using MacConkey plates. MacConkey plates contain two color 
indicators which demonstrate whether the cells utilize the carbon source. Genetic screens 
versus genetic selections (MacConkey vs. minimum media) often have the advantage that 
the stress-response is not activated which typically reduces the occurrence of spontaneous 
mutations (Bjedov et al. 2003).  
MBP has been extensively used as a reporter for the genetic analysis of the Sec 
pathway and represents a paradigm of post-translational protein export. MBP folds 
rapidly and therefore is competent for Tat export.  MBP fused to a Tat signal peptide 
restores growth of malE mutants on maltose plates. By deleting one the components of 
Tat, no growth can be observed indicating that the protein is exported via Tat.  
 
1.6.3 GFP-SsrA 
The green fluorescent protein from the jellyfish Aequorea victoria has been 
widely used as a marker for gene expression and protein localization. The chromophore 
in GFP is generated by a spontaneous cyclization and oxidation of the sequence Ser65-(or 
Thr65)-Tyr66-Gly67, forming a p-hydroxybenzylidene-imidazolidone (Cody et al. 1993). 
However, when GFP is exported through the Sec translocon, it assumes a non-fluorescent 
fold in the periplasm. For unknown reason, fluorescent GFP can only be achieved in E. 
coli when it its folding maturation occurs in the cytoplasm (Feilmeier et al. 2000; Santini 
et al. 2001). Since Tat substrates fold prior export in the cytoplasmic environment, GFP 
can be employed as a reporter for Tat export. However, only around 50% of the 
fluorescent GFP is exported whereas the rest remains in the cytoplasm.  For this reason 
the total cell fluorescence cannot be used to determine the localization of the protein.  In 
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order to detect fluorescence only originating from periplasmic GFP, DeLisa et al. used a 
C-terminal SsrA degradation tag. The small ssrA RNA (small stable RNA A) was 
discovered when the expression of murine interleukine-6 (IL-6) in E. coli resulted in 
several truncated versions with each containing an addional C-terminal 
AANDENYALAA sequence (Tu et al. 1995). Except for the first alanine, all of these 
amino acids are encoded within the open reading frame of the ssrA RNA. It turns out that 
the bacteria cell uses the aminoacylated-SsrA RNA to exchange mRNA in stalled 
ribosomes giving rise to a polypeptide with a C-terminal SsrA peptide tag. The 10 amino 
acids of the SsrA peptide tag directly recruit the tagged truncated protein to the ClpXP 
degradation machinery (Karzai et al. 2000).  
In summary, by artificially tagging GFP with a SsrA sequence, GFP that is not 
sequestered away from the cytoplasm by transport through the Tat pore is immediately 
sent to the cellular degradation machinery  and eliminated (DeLisa et al. 2002).  Thus cell 
fluorescence is now proportional to the extent of export of GFP-SsrA into the periplasm.   
 
1.7 PHAGE DISPLAY 
Phage display has been commonly used as an in vitro screening method for 
isolating polypeptides out of a library of different variants (Smith 1985). Phage display 
allows the display of polypeptide on the outside of a phage particle and combines the 
genetic information encoding the displayed protein by placing it inside the phage particle. 
The displayed protein is typically either encoded in an artificial phagemid or it is directly 
integrated into the viral genome. A phagemid is simply a plasmid that, in addition to a 
bacterial plasmid origin of replication, bears a phage-derived origin of replication that 
promotes packaging into the phage particle. To promote the display of a protein or 
polypeptide of interest, it is expressed as a fusion to one of the phage envelop proteins. 
Since a phagemid does not contain the information for all other phage proteins, cells 
carrying a phagemid require a superinfection with a helper phage containing remaining 
phage genes to assure phage propagation (Table 1.2). For phage display, typically 
filamentous phages such as f1, M13 or fd are utilized. The advantage of using 
filamentous phage over lytic phage (such as T4, T7 or lambda) is that filamentous phage 
is directly secreted into the media from which it can be easily purified. The phage 
assembly process takes place while bacteria are still allowed to grow (around 50% slower 
duplication time) and phage particles are continuously secreted. Further, the membrane 
potential is maintained. Secretion into the media simplifies the purification of phage 
particles tremendously. A polyethylene glycol precipitation step (with high salt 
concentration) is sufficient to extract the phage from the culture supernatant. This avoids 
contamination with cytoplasmic proteins during the panning step and removes proteases. 
 
 




Proteins are typically anchored onto the phage particle by fusion with either the 
pVIII or the pIII protein. The use of the N-terminus of pIII protein as a fusion partner 
allows the display of about 3-5 copies of the desired protein per phage particle (Scott and 
Smith 1990) whereas the fusion to the major coat protein pVIII can result in the display 
of up to 2700 copies of small (up to six amino acids) peptides (Greenwood et al. 1991) 
(Figure 1.12). The amount of displayed protein or polypeptide can be varied depending 
on which phage-display vector is used. However, when using the complete phage genome 
as a vector and the protein is fused to all pIII or pVIII particles, the viability and 
infectivity of the phage might be affected depending on the size of the protein. 
 
 






Display on all 
or some 











Type 3 pIII All 1 phage 
Type 8 pVIII All 1 phage 
Type 33 pIII some 2 phage 
Type 88 pVIII some 2 phage 
Type 3+3 pIII some 2 phagemid 
Type 8+8 pVIII some 2 phagemid 
 
 
During synthesis of a phage particle, the envelop protein pIII, and the assembly 
proteins pI, pIV and pXI are presumably inserted via Sec into the cytoplasmic membrane, 
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in a  SecA dependent manner (Rapoza and Webster 1993). pIII contains an N-terminal 
signal peptide. Hence, genes fused to pIII are typically inserted between the signal 
peptide and the mature part of pIII. pVIII on the other hand inserts spontaneously into the 
membrane a process that occurs at slower rates depending on the size of the fusion 
polypeptide (Malik et al. 1998).  
Most phage display systems are based on pIII fusions which are exported using 
the signal peptide of the Erwinia carotovora pectate lyase PelB that mediates efficient 
post-translational Sec transport. However recently it was  recently demonstrated that 
proteins that are highly prone to aggregation, such as Ankyrin Repeat Proteins 
(DARPins), are more efficiently displayed when targeted to the co-translocational Sec 
pathway e.g. by a DsbA signal peptide (Steiner et al. 2006).   
 
1.8 BIOTECHNOLOGICAL IMPACT OF THE TAT PATHWAY 
 
The sales of recombinant therapeutic proteins exceed $30 billion per year as of 
2004 (Walsh 2005) and are projected to reach $70 billion by the end of the decade. 38% 
of the newly approved protein-based therapeutics (2003-2006) are engineered. Many 
therapeutic proteins are produced commercially using Escherichia coli. E coli is easy, 
fast and inexpensive to grow in large scale. Its main limitation remains in the lack of a 
mammalian post-translational modification apparatus especially protein glycosylation 
which often affects it biological function. Many proteins containing disulfide bonds can 
be expressed in E coli by export into the oxidative periplasm where disulfide bridges are 
formed.  One example of disulfide containing proteins are antibodies. 
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The special features of the Tat pathway are useful for biotechnological 
applications related to protein therapeutics. Different technology platforms have been 
derived using the Tat pathway’s inherent folding proof-reading mechanism.   
 
1.8.1 Solubility and folding kinetics  
The expression and purification of many eukaryotic proteins is limited by 
aggregation.  Fisher and coworkers developed a screening technology that capitalizes on 
the folding quality control mechanism of the Tat pathway for the isolation of protein 
mutants that are resistant to aggregation. Their genetic screen employs a tripartite fusion 
consisting of the protein of interest, sandwiched between an N-terminal Tat signal 
peptide and an export reporter such as beta lactamase at its C-terminus. Export of the 
fusion occurs only when both the desired protein and the reporter are able to fold 
properly.  Using this screening platform, Fisher et al. were able to isolated higher soluble 
variants of library of randomly mutagenized Aβ42 peptide precursor protein.  
In an independent study, Ribnicky and coworkers optimized the folding of a scFv 
by applying the Tat pathway as a folding filter. A randomly mutaganized library of the 
scFv 26-10, a scFv antibody fragment binding to digoxin,  was  screened by flow 
cytometry for increased expression and binding to fluorescent hapten (Ribnicky et al. 
2007). Isolated variants contained mutations only within the framework regions of the 
antibody fragment and not in the binding loops. In vitro analysis of the folding kinetics 
revealed that the isolated scFv variant proteins exhibit faster folding kinetics and a lower 
rate of off-pathway aggregation. Hence, this work demonstrated that the Tat pathway can 
not only function as a selective filter for higher solubility, but also it can allow the 
isolation of faster folding protein variants. This is opposite to folding selections 
 39
employing export via Sec in which case mutants exhibiting slower folding kinetics are 
isolated (Huber et al. 2005b). 
 
In summary, export pathways can be exploited in selections for different folding 
properties in a protein of interest. A genetic screen established on the posttranslational 
Sec pathway promotes the isolation of slower folding variants, whereas the Tat pathway 
allows isolation of variants with faster folding kinetics and increased solubility. Both 
methodologies are of interest for the optimization of the biotechnological expression of 
therapeutic proteins or to understand the molecular basis of disease-promoting and 
misfolded proteins as for the case of the amyloid precursor protein involved in the 
generation of the Alzheimer disease.   
 
1.8.2 Protein-protein interactions 
1.8.2.1 A bacterial two-hybrid system 
Based on the fact that the Tat pathway is able to export substrates with multiple 
subunits only one of which contains a signal peptide (“hitchhiker export”) (Rodrigue et 
al. 1999) a new bacterial two-hybrid system was developed (Strauch and Georgiou 
2007a). The detection of interacting proteins capitalizes on the folding quality control 
mechanism of the Twin Arginine Transporter (Tat) pathway and the hitchhiker export of 
the two interacting proteins. One protein (bait) is expressed as a fusion to a Tat signal 
peptide whereas the second protein (prey) is fused to a protein reporter that can confer a 
phenotype only after export into the bacterial periplasmic space. Since the prey-reporter 
fusion lacks a signal peptide, it can only be exported as a complex with the bait-signal 
peptide fusion which is capable of targeting the Tat translocon. Using maltose-binding 
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protein as a reporter, clones expressing interacting proteins can be grown on maltose 
minimal media or on MacConkey plates. In addition, export of a signal peptide-prey:bait-
DsbA complex into the periplasm allows complementation of dsbA- mutants and restores 
the formation of active alkaline phosphatase, which in turn can be detected by a 
chromogenic assay.  This particular matter will be discussed in chapter 2. 
 
1.8.2.2 Tat-based phage display   
Conventional phage display is based on the export of the displayed protein 
through the Sec pathway which limits the folding environment of the protein of interest 
(POI) to the periplasmic space. In a Tat-based phage display, the POI is translocated 
through the Tat pore whereas the pIII protein is sent out through the Sec pathway. 
Association of the POI is mediated in the periplasm by the interaction of Fos and Jun 
containing a leucine zipper. The interaction of their adaptor proteins can be stabilized by 
cysteine residues (Paschke 2005, Tullman-Ercek unpublished results). This system will 
be discussed in chapter 4.  
 
1.9 THE INVOLVEMENT OF TAT PATHWAY IN PATHOGENICITY 
 
Bacterial pathogenicity depends on the ability of the organism to secret virulence 
factors. Virulence factors are either displayed on the surface of the cell or secreted into 
extracellular space. The Tat pathway has been proven to contribute to bacterial 
pathogenicity to plants and mammals. Homologues of the Tat components have been 
discovered in Pseudomonas aeruginosa (Ochsner et al. 2002), Listeria monocytogenes 
(Desvaux and Hebraud 2006), Legionella pneumophila (Rossier and Cianciotto 2005),  
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Streptomyces coelicolor (Widdick et al. 2006), Staphylococcus aureus (Yamada et al. 
2007), Yersinia (Lavander et al. 2007) and enterohemorrhagic Escherichia coli O:157:H7 
(Pradel et al. 2003)  with varying impact on their virulence.  
For example in Pseudomonas aeruginosa, 18 different Tat substrates were 
identified (Ochsner et al. 2002). Tat export was shown to be essential for phospholipases, 
and proteins involved in pyoverdine-mediated iron-uptake, anaerobic respiration, osmotic 
stress defense, motility, and biofilm formation. Infection of rat lungs with a Tat deletion 
mutant of P. aeruginosa resulted in low inflammatory responses and no pulmonary 
abscesses (Ochsner et al. 2002). In the enterohemorrhagic E. coli O 157:H7 is was 
demonstrated that the secretion of the Shiga toxin 1 (Stx1) as well as the H7 flagellin was 
dependent on a functional Tat pathway (Pradel et al. 2003). 
The phytotoxicity of P. syringae is mediated by the Tat-dependent export of  two 
extracellular phospholipase C (PLC) that caused major damage to Arabidopsis thaliana 
(Bronstein et al. 2005). Pseudomonas syringae pv. tomato DC3000 (DC3000) causes 
diseases in Arabidopsis thaliana and tomato plants, as well as a hypersensitive response 
in non-host plants such as Nicotiana tabacum and Nicotiana benthamiana.  
 
Since the Tat pathway is highly conserved among bacteria and archaea and all Tat 
homologues have been extinguished in the mitochondrial genome of mammalian cells 





1.9.1 Quorum sensing and the Tat pathway 
The Gram-negative bacterium Providencia stuartii is responsible for nosocomial 
and opportunistic infection in humans and causes urinary tract infections. Accumulation 
of extracellular factors represses the activity of the enzyme 2-N-acetyltransferase 
[AAC(2')-Ia] (Rather et al. 1997). AAC(2')-Ia normally involved in both peptidoglycan 
and aminoglycoside acetylation as a general house-keeper enzyme. Originally, it was 
identified as an enzyme which confers the ability of aminoglycoside resistance when 
overexpressed (Clarke 1993) The precise extracellular compound causing a quorum 
sensing response has not been identified so far. The regulation of AAC(2')-Ia is 
influenced by at least 5 different genes which act as negative regulators, one of which is 
the rhomboid protease AarA (Macinga and Rather 1996). Mutations in the aarA gene 
results in loss of pigment production and in cell division causing chain formation (Rather 
and Orosz 1994) similar to a tat mutant. AarA is a member of the rhomboid family of 
intramembrane serine proteases which are ubiquitously found in prokaryotes and 
eukaryotes and are highly conserved. In general, rhomboid proteases are involved in the 
regulation of growth factor signaling, mitochondrial fusion, and parasite invasion. The 
only identified substrate of AarA in P. stuartii so far is a TatA homologue which has an 
additional 7 amino acid residues at its N-terminus. Without cleavage of these residues by 
AarA, the Tat pathway remains non-functional (Stevenson et al. 2007)/ Hence through 
the activation of the quorum sensing regulated rhomboid protease the activation of the 





1.10 RESEARCH OUTLINE 
 
Protein export is employed in a variety of biotechnological applications (such as 
phage display, cell surface display, antibody expression and folding maturation) which 
mainly rely on the export via the Sec pathway. Proteins exported by the Sec pathway are 
extruded across the lipid bilayer in an unfolded state, which excludes the utilization of the 
cytoplasmic folding machinery. Transport via the Tat pathway can circumvent some of 
these limitations, because it (i) allows proteins to fold within the cytoplasm and further 
(ii) the because of the folding quality by the Tat machinery. 
As described in chapter 2, we developed a new methodology that capitalizes on 
the inherent folding proof-reading mechanisms of the Tat pathway and its ability to 
export more than one subunit via the hitchhiker mechanism. In the new bacterial two-
hybrid system, the “signal” (growth or enzymatic activity) can only be detected when the 
bait-reporter fusion binds to the bait fused to a Tat signal peptide and then both fusion 
constructs are then exported together via the Tat mediated hitchhiker mechanism. In 
chapter 4, we describe efforts to use a Tat-based phage display system to isolate GFP 
variants that bind to different target proteins of interest from libraries of random peptides 
inserted within a permissive loop of the protein. GFP is a protein that requires folding in 
the cytoplasm of Escherichia coli in order to be functional and therefore it cannot be 
fluorescently displayed on a phage particle by the conventional phage display system.   
The second aspect of this research was aimed at understanding the molecular 
mechanism of the Tat pathway. Biochemical evidence had suggested that the recognition 
of the Tat signal peptide is mediated by the receptor complex formed by TatB and TatC. 
We established genetically the importance of TatC as the crucial component that 
recognizes the twin-arginine motif within the Tat signal peptide. This work is described 
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in chapter 3. We identified several amino acid substitutions within TatC that allow an 
alteration of the substrate specificity of TatC enabling the export of proteins with 
defective signal peptides. Finally, in the appendix, we describe analysis of TatA as a GFP 
fusion, combined with proteinase K accessibility analyses, as well as the incorporation of 




A bacterial two-hybrid system based on the twin-arginine transporter 




 In recent years, the numbers of genes identified in a broad spectrum of organisms 
has grown exponentially. A major challenge will be categorizing the corresponding 
proteins into their functional units within the cell. Several approaches have been used to 
assign newly identified proteins into cellular networks (Galperin and Koonin 2000; Bork 
et al. 2004; de Lichtenberg et al. 2005). In vitro, interacting proteins can be detected by 
mass spectrometry or by chromatographic techniques, typically following genetic fusion 
with an appropriate affinity tag (Rigaut et al. 1999; Gavin et al. 2002; Butland et al. 
2005). In vivo, genetic techniques for the identification of interacting proteins rely mainly 
on two-hybrid systems and protein complementation assays. A number of such 
techniques have been developed and used extensively in E. coli (Hu 2001; Karimova et 
al. 2002; Karimova et al. 2005). So far, the detection of protein interactions in bacteria 
has capitalized on fusions to transcriptional repressors such as λcI, LexA or AraC, 
transcriptional activators (involving the recruitment of RNA polymerase or the 
dimerization of the Vibrio cholera ToxR), complementation of biosynthetic enzymes 
such as dihydrofolate reductase, or signaling enzymes, e.g. the Bordetella pertussis 
adenylate cyclase. Ultimately, the binding of bait and prey is manifested as a change in 
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the activity of a reporter enzyme which in turn allows for colony formation on selective 
plates or can be measured quantitatively using chromogenic substrates. A common 
complication with genetic methods for the discovery of interacting proteins is a high rate 
of false positives (Fields 2005).  False positives can result when one of the two partner 
proteins alone can trigger a change in the activity of the reporter, for example through 
spurious binding to DNA that alters transcriptional activation/repression, or as a result of 
non-specific binding events. Misfolding of the prey or bait gives rise to “sticky” proteins 
having exposed hydrophobic regions that can engage in non-specific interactions and 
therefore result in false positives.   
 This chapter describes the development of a bacterial two-hybrid system that 
capitalizes on the biological folding quality control mechanism that is inherent to the 
Twin Arginine Translocation (Tat) pathway for protein export. The Tat pathway of 
bacteria, archaea and plants is responsible for the translocation of folded proteins across 
energy transducing membranes (Berks 1996; Palmer et al. 2004; Lee et al. 2006; Sargent 
et al. 2006). In that regard, the Tat pathway is fundamentally different from the general 
secretory (Sec) pathway in which proteins traverse membranes in an unfolded 
conformation by threading through the SecYEG (Sec61αβγ in eukaryotes) pore. The Tat 
pathway mediates the export of proteins that must assemble with cofactors within the 
reducing environment of the cytoplasm. In addition, certain Tat precursors associate with 
other polypeptides in the cytoplasm that do not contain signal peptides.  In a process 
called “hitchhiker export”, the two polypeptides form a complex that is targeted to the 
Tat translocation apparatus and then is exported to the periplasm by virtue of the signal 
peptide in the precursor (Rodrigue et al. 1999). In the absence of the assembly partner or 
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when cofactor assembly has been impaired by mutation, protein export through Tat does 
not take place (Halbig et al. 1999; Rodrigue et al. 1999). These observations together 
with in vitro and genetic evidence point to a protein folding quality control mechanism 
that is intrinsic to Tat translocation (DeLisa et al. 2003). As a result of the folding quality 
control feature of the Tat pathway only folded proteins are accepted for translocation 
across the membrane.   This feature of the Tat pathway was recently exploited to develop 
a screen for protein solubility (Fisher et al. 2006).  
 We reasoned that the ability of the Tat pathway to discriminate against misfolded 
polypeptides may be useful for protein interaction analysis.  Thus, we developed a two-
hybrid system that capitalizes on “hitchhiker export” as well as on the folding quality 
control features of Tat (Fig. 2.4). We have used two reporter systems for the detection of 
protein:protein interactions via the “Tat two-hybrid assay”: one based on growth on 
selective media or MacConkey plates and a second, based on an enzymatic assay that 
relies on the oxidation of alkaline phosphatase in the periplasm, resulting in the formation 
of active enzyme that is then detected using a chromogenic substrate.   
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2.2 MATERIAL AND METHODS 
2.2.1 Bacterial strains 
 
Bacterial cultures were routinely grown on Luria Bertani (LB) Medium, in liquid 
culture overnight at 37°C and 250 rpm, and on solid LB medium, containing 1.5% agar 
overnight at 37°C. Utilized strains are summarized in Table 2.1 
Table 2.1. Bacterial strains 
Strains Genotype  Source  
CC160 F- thr leu thi lacY galK galT ara fhuA tsx dam dcm supE44 Lab 
collection 
HS3018 F-, araD139 ∆ (argF-lac) U169  flbB5301 deoC1 ptsF25 
relA1 rbsR22 rpsL150 thiA malT(Con)-1 ∆malE444 
Shuman 
1982 
MC1000 araD139  ∆(araA-leu)7679   (codB-lac)X74  galE15 galK16 
rpsL150 relA1 thi [F+ proAB, lacIq, lacZ ΔM15, Tn(tetR)] 
Lab 
collection 
MCA MC1000, ∆dsbA::kan Lab 
collection 
Xl-1 blue recA1, endA1, gyrA96, thi, hsdR17, supE44, relA1, lac, [F+ 
proAB, lacIq, lacZ ΔM15, Tn(tetR)] 
Stratagene 
 
2.2.2 Plasmid constructions 
Plasmids used in this work are summarized in Table 2.2 and oligonucleotides in 
Table 2.3.  
Table 2.2. Plasmid constructs  
Plasmids Genotype Reference 
pEMSI Cm, pACYC replicon, trc promoter This study 
pEMS11 Cm, pACYC replicon, ptrc wbfos::∆ssmalE This study 
pEMS12 Amp, pTrc99 replicon, , ptrc sstorA::wbjun This study 
pEMS13 Cm, pBAD33 replicon, pBAD wbfos::∆ssdsbA This study 
pEMS14 Cm, pBAD33 replicon, pBAD ∆ssdsbA::im2 This study 
pEMS15 Amp, pTrc99 replicon, ptrc sstorA::E2 This study 






























Plasmid pEMSI was constructed by removing the araC regulator gene, the pBAD 
operator and promoter region of pBAD33 (Guzman et al. 1995) and replacing them with 
a 220 bp fragment 5’ of the ATG codon in pTrc99A. The latter fragment (with ClaI and 
HindIII restriction sites) was amplified with the primers EMS11 and EMS12. wbfos was 
amplified with EMS110 and EMS111, and ∆ssmalE with EMS18 and EMS19. wbfos was 
inserted upstream of ∆ssmalE into pEMSI using the SacI, XbaI and HindIII cut sites for 
these two genes, resulting in pEMS11 (Figure 2.1). 
 
 
Figure 2.1. Plasmid map of pEMSI 
 The intermediate plasmid construct pTrc99-ssTorA was generated by 
amplifying sstorA with the primers EMS13 and EMS14 and inserting into pTrc99 
between the NcoI and XbaI sites. wbjun was amplified with primers EMS16 and EMS17 
and ligated into pTrc99-ssTorA using the XbaI and HindIII sites, giving rise to pEMS12.  
The KK version of the TorA signal peptide was generated as above, but using EMS15 as 
5’ primer, generating plasmid pEMS16.  
 
For the construction of the wbFos-∆ssDsbA fusions, wbfos was amplified with the 
primers EMS112 and EMS111, digested with SacI and XbaI and inserted into pBAD33.  
In addition, ∆ssdsbA was cloned directly downstream using the primers EMS113 and 
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EMS114, producing pEMS13. The DNase domain of colicin E2 was amplified from the 
plasmid ColE2-P9 (Mock and Schwartz, 1978) with the primers EMS115 and EMS116 
containing a codon change of H575A and a 5’ strep2 tag sequence. After digestion with 
XbaI and HindIII, the DNase domain was inserted downstream of ∆sstorA in pTrc99-
ssTorA, generating pEMS15.  
 Plasmid pEMS14 was generated by PCR amplification of ∆ssdsbA with 
the primers EMS117 and EMS118 using genomic DNA and then insertion of ∆ssdsbA in 
between the SacI and XbaI site of pBAD33, whereas immunity protein 2 was inserted 
downstream of ∆ssdsbA between XbaI and HindIII using primers EMS119 and EMS120 
containing an additional FLAG tag at the 3’ site. The 5’ position of ∆ssdsbA allows an 
easy exchange of bait and prey since the restriction sites are compatible with the signal 
peptide construct.  
 
 
Figure 2.2. Plasmid map of pBAD33 constructs containing the DsbA reporter fusions 
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2.2.3 Media and buffer composition  
Table 2.3 Summary of growth media  
Medium Component % w/v or %v/v or mM 





















MacConkey medium Peptone 
Proteose Peptone 


























(induction medium for 
alkaline phosphatase) 
10x MOPS salts  
glucose  
casamino acids   
adenine  
thiamine  







MOPS salts (10x) 3-(N-morpholino)propanesulfonic 
acid (pH 7.4) (MOPS)  



















2.2.4 Preparation of electrocompetent cells 
Flasks containing 500 ml of YENB low salt medium were incubated with 3 ml of 
an overnight culture of the desired strain. Cultures were grown at 37˚C or 30˚C as 
described, until an O.D.600 of 0.6 was reached. Cells were harvested by centrifugation at 
10,000g for 15 min at 4°C. Cells were re-suspended in ice-cold dH2O and centrifuged 
again. This washing step was performed once more and a third time with 15 % glycerol 
instead of dH2O.  The final centrifugation step was extended to 20 min and cells were re-
suspended into a final volume of 1.125 ml per 500 ml original culture volume in 15% 
glycerol. The cell suspension was aliquoted and immediately stored at -80°C. 
 
2.2.5 Alkaline phosphate activity assays  
 
Cells were grown overnight in low phosphate MOPS minimum media (Sambrook et al. 
2000) with Peptone P (USBiological) as an amino acid source,  subcultured (1/20) into 1 
ml low phosphate medium and induced with 0.04% arabinose at OD600 0.4. Around 6 h 
after induction, cultures were diluted with media to OD600 1.0; 20 µl of cell cultures were 
transferred to a 96 well plate and mixed with 30 μl of lysis buffer, a 2:1 mixture of B-
PER (78248 Pierce Biotechnology, Inc.) with 0.4 M iodoacetamide (Sigma) for 30 min. 
As substrate for AP, 200 µl of 250 µg/ml p-nitrophenyl phosphate (Sigma) in 0.250 M 
Tris-HCl pH 8 was added to each well and hydrolysis was measured at A405 on a plate 
reader (BioTek). 
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2.2.6 Carbon source selection assays 
Cells containing the desired plasmid combinations were grown overnight at 37˚C 
in LB medium, washed in M9 minimum media, diluted 106 fold and plated. 
For minimal media growth selections and plating on MacConkey agar, the growth 
media was supplemented wth 0.4% maltose. On minimal media plates with maltose as 
the carbon source, colonies appeared after 4-5 days of incubation at 37˚C.  For 








As indicated in Figure 2.4, the bait is fused in frame to the C-terminus of a Tat 
signal peptide. One of the best studied Tat signal peptides is ssTorA of the E. coli 
trimethylamine N-oxide reductase (TorA) and it is selected for the present study.  The 
prey was expressed as a fusion to a reporter that has to be translocated to the periplasm 
for function.  Since the prey-reporter fusion does not contain a signal peptide, it is unable 
to interact with the Tat translocation pore and therefore remains sequestered within the 
cytoplasm.  However, binding of the prey to the signal peptide-bait fusion results in the 
formation of a protein complex that can be targeted to the Tat translocon and then be 
exported into the periplasm.   
The maltose-binding protein, MBP, is encoded by the malE gene and has been 
used extensively as a fusion partner in protein export studies and to aid protein solubility 
(Boos and Shuman 1998; Kapust and Waugh 1999; Blaudeck et al. 2003). The export of 
MBP to the periplasm can be detected easily on MacConkey agar plates or by growth on 
maltose as the sole carbon source. Signal sequence-less ∆ssMBP prey fusions were 
expressed under the control of the ptrc promoter in the low copy number plasmid pEMSI 
(pACYC origin of replication).  The signal peptide-bait fusion was similarly transcribed 
from a ptrc promoter on a compatible plasmid vector containing a pBR322 origin. To 
avoid cell toxicity due to the high level of expression of the two fusion proteins, we relied 
on leaky transcription from the ptrc promoter in the absence of inducer. As discussed 
below, the basal level of transcription from uninduced cells is sufficient to give a high 
signal to noise ratio.      
  
 
Figure 2.4. Generalized scheme for Tat-based two-hybrid system. A pACYC-derivative 
plasmid expresses the prey fusion to a reporter protein; the fusion can be 
either C- or N-terminal to the reporter. A compatible pBR322 replicon 
expresses the bait C-terminal of a Tat signal peptide. Interaction of the bait 
and prey allows export of the resulting complex through the twin-arginine 
transporter.  In the periplasm, the specific activity of the reporter can be 
detected.  





2.3.1 Maltose binding protein as a reporter for export 
 
As model bait and prey proteins, we used the leucine zipper domains of the 
transcription factor wbfos (rat, aa 161-200) and wbjun (rat, aa 227-315) respectively 
(Abate et al. 1990; Crameri and Suter 1993). These two domains represent one of the 
prototypical systems for interacting proteins (Kouzarides and Ziff 1988) with a KD of 70 
nM (Oyama et al. 2006). Plasmids encoding wbFos-∆ssMBP (pEMS11) and ssTorA-
wbJun (pEMS12) were transformed into the E. coli malE- strain HS3018 and plated on 
MacConkey agar plates. Bacteria containing either plasmid alone gave rise to yellow-
orange colonies revealing their inability to utilize maltose as the carbon source. In 
contrast, cells co-transformed with pEMS11 and pEMS12 acquired the ability to grow on 
maltose and formed red colonies after growth for 14 h at 37˚C (Fig. 2.5.A.2). Substitution 
of the twin arginine dipeptide with a pair of lysines completely abolished Tat export 
(DeLisa et al. 2002; Ize et al. 2002): cells expressing the ssTorA(KK)-wbJun (pEMS16) 
gave rise to yellow-orange colonies (Fig. 2.5.A.1) indicating that the mal+ phenotype 
shown in Fig. 2.A.2 was dependent on  Tat export. Additionally, only cells transformed 
with both plasmids and encoding a wt ssTorA signal sequence formed colonies on 
minimal media plates with 0.4% maltose as the carbon source (Fig. 2.5.A.4). No colony 
growth was observed for the ssTorA(KK) fusion whereas the wt ssTorA showed growth 





Figure 2.5. Detection of interacting proteins via Tat two-hybrid using MBP as reporter. 
(A) Use of MalE as a reporter:  Panel 1: E.coli HS3018 (malE) cells co-
expressing ssTorA(KK)-wbJun fusion with a non-functional Tat signal 
peptide (from pEMS16) and wbFos-MBP (from pEMS11) grown on 
MacConkey plates with 0.4% maltose. Panel 2:  E.coli HS3018 (malE-) co-
expressing ssTorA-wbJun (pEMS12) with wbFos-MBP (pEMS11) grown 
on MacConkey plates with 0.4% maltose. Panel 3:  Cells as in Panel 1 
plated on M9 media with 0.4% maltose and incubated for 4 days at 37˚C.  
Panel 4: Cells as in Panel 2 grown on maltose minimal media plates as in 
panel 3. (B) Interaction of the prey-ΔssMBP fusion with ssTorA-bait results 
in a complex that is co-translocated into the periplasm by the Tat pathway 
via the ssTorA signal peptide.  In the periplasm MBP channels maltose to 
the maltose uptake apparatus which allows the cells to catabolize maltose as 
a carbon source.  
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2.3.2 Disulfide bridge formation as indicator for protein interactions 
 
We then sought to develop an enzymatic assay for the export of the ssTorA-
bait:prey-reporter complex into the periplasm.  However, we could not take advantage of 
the widely used periplasmic reporter alkaline phosphatase (AP) because it has to fold in 
the cytoplasm before it can be exported via Tat (DeLisa et al. 2003). Cytoplasmic folding 
of AP can only be accomplished in specialized oxidizing mutant strains (Bessette et al. 
1999).  In addition, the large size of the folded AP, 94 kDa, (Bradshaw et al. 1981) limits 
the size of the bait and prey proteins in the fusions because it is unlikely that the Tat pore 
can accommodate signal peptide-bait:prey- complexes larger than  160-180 kDa (Santini 
et al. 2001). Similarly, β-lactamase which has been used as a periplasmic reporter 
enzyme is not suitable for our purposes because: (a) β-lactamase can fold into an active 
conformation within the cytoplasm and therefore the enzymatic activity in total cell 
lysates is not indicative of export and (b) a low level export and resistance to ampicilin is 
observed in cells expressing signal sequence-less β-lactamase (Bowden et al. 1992).  
We elected to investigate the utility of the periplasmic cysteine:disulfide 
oxidoreductase DsbA as a periplasmic reporter (Fig. 2.7.A).   In bacteria, the oxidation of 
protein thiols to form disulfide bonds normally occurs in the periplasm and is catalyzed 
by DsbA (Kadokura et al. 2003). DsbA, a thioredoxin superfamily protein, is a highly 
efficient catalyst of disulfide bond formation.  Its activity depends on recycling by the 
membrane-bound DsbB enzyme which in turn transfers electrons to the quinones and 
ultimately, to the respiratory chain (Nakamoto and Bardwell 2004). The folding of 
alkaline phosphatase in the periplasm is dependent on oxidation by DsbA.  In the E.coli 
dsbA- mutant MCA (MC1000 ∆dsbA::kan) grown in low phosphate MOPS minimum 
media, AP activity is about 20-fold lower compared to the isogenic control (Figure 2.C). 
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The level of residual AP activity is partly dependent on the Fe(II) concentration in the 
growth media (data not shown).   
  wbFos-∆ssDsbA was expressed from the arabinose inducible promoter in 
plasmid pEMS13 to allow differential expression of the bait and prey fusion proteins.   
Plasmids pEMS12 and pEMS13 were co-transformed into E.coli MCA and grown in low 
phosphate media to induce the expression of AP from the chromosomal phoA gene. The 
synthesis of the wbFos-∆ssDsbA expression from pEMS13 was induced during 
logarithmic phase (O.D.600 ~0.4) with 0.04% arabinose. Cells were harvested around 6 
hours after induction, lysed, free thiols were blocked with the sulfhydryl alkylating agent 
iodoacetamide to prevent oxidation of any reduced AP after lysis (Derman and Beckwith 
1991) and the enzymatic activity was determined using the chromogenic substrate pNPP 
(Fig. 2.C).  Cells expressing wbFos-∆ssDsbA alone had an AP level slightly above 
background whereas co-expression of ssTorA-wbJun from pEMS12 resulted in nearly 
complete restoration of AP activity to the level observed in cells expressing authentic 
DsbA from the chromosomal gene. Colicin E2 (E2) and the immunity protein 2 (Im2) 
constitute a pair of toxin:antitoxin proteins that interact with high affinity (KD=10-15 M). 
Im2 binds to the endonuclase domain of Colicin E2 with a 1:1 stoichiometry to inhibit 
cleavage of DNA prior to export from the cytoplasm. Garinot-Schneider and coworkers 
described several mutations that abolish DNase activity (Garinot-Schneider et al. 1996). 
A gene encoding the 86 aa Im2 protein was fused 3’ of ΔssdsbA gene giving rise to 
pEMS14.   The C-terminal cloning of Im2 introduced the same restriction sites as those 
used for the signal peptide-bait plasmid; thus, bait and prey genes can be easily 
interchanged between the two plasmids encoding the signal peptide and the reporter 
fusion. The H575A mutation that disables the active site was introduced in ColE2 (aa 
479-582) and the resulting gene was fused to the C-terminus of ssTorA (pEMS15). Cells 
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expressing both ssTorA-E2 in pEMS15 and ∆ssDsbA-Im2 in pEMS14 exhibited high AP 
activity (25-fold above background, Figure 2.C). As expected, expression of ∆ssDsbA-
Im2 alone gave a very low level signal. We further examined whether the expression of 
non-interacting proteins would give us any AP activity. We tested wbFos-∆ssDsbA with 
the endonuclease domain of colicin E2, ssTorA-wbJun with immunity protein 2, and 
additionally examined whether the immunity protein could have any dimerization 
properties using ssTorA-Im2 and Im2-∆ssDsbA. None of these three protein fusion pairs 





Figure 2.6. Detection of protein:protein interactions by an enzymatic assay using DsbA as 
a reporter. (A) Interaction of the prey-ΔssDsbA fusion with ssTorA-bait 
results in the formation of a complex that is translocated into the periplasm 
by the Tat pathway via the ssTorA signal peptide.  In the periplasm DsbA 
catalyzes the oxidative folding of AP the activity of which can be detected 
using the chromogenic substrate pNPP. (B) Alkaline phosphatase activity in 
arbitrary units (au). Cells were grown in MOPS low phosphate media with 
or without 0.04% arabinose, harvested after 6 hours and the AP activity was 
measured as described in the Material and Methods section.  E. coli 
MC1000 (positive control); MCA (MC1000 ΔdsbA::kan) (negative control); 
Im2:  E.coli MCA expressing ∆ssDsbA-Im2 from pEMS14; Fos: MCA 
expressing wbFos-∆ssDsbA from pEMS13. Im2:E2: co-expression of the 
∆ssDsbA-immunity protein 2 fusion from pEMS14 together with the 
ssTorA-endonuclease domain of colicin E2 (H575A) fusion from pEMS15; 
Fos:Jun: co-expression of ssTorA-wbJun from pEMS12 with the  wbFos-
∆ssDsbA fusion (pEMS13); Jun:Im2: co-expression of ssTorA-Jun from 




2.4 DISCUSSION AND CONCLUSIONS  
 
 We have developed a new genetic assay for the detection of protein:protein 
interactions by capitalizing on the unique features of the Tat export pathway of E.coli. To 
our knowledge, this is the first protein interaction assay that takes advantage of protein 
translocation across an energy transducing membrane, namely the cytoplasmic membrane 
of E.coli.  Extensive studies have shown that only folded proteins can be translocated via 
the Tat pathway, including proteins comprising of two or more interacting polypeptides 
only one of which contains a signal sequence. Rodrigue et al. (1999) first coined the term 
hitchhiker export after observing that the large subunit HybC of the E. coli hydrogenase 
2, which does not contain a signal peptide, was translocated as a complex with HybO 
which contains a 37 aa long Tat signal peptide. More recent studies demonstrated that a 
dimeric FAB antibody fragments can also be exported by a hitchhiker mechanism via a 
signal peptide on only one of the two polypeptides that comprise the FAB protein (DeLisa 
et al. 2003).  In our approach, one protein is fused to a Tat signal peptide and the second 
protein to a protein reporter that can confer a phenotype only upon export into the 
periplasmic space. We demonstrated the detection of interacting proteins via the Tat two-
hybrid system using two periplasmic reporters: maltose-binding protein, whose export 
can be detected either by selecting for growth on maltose or on MacConkey plates, and 
DsbA which catalyzes the formation of active AP in the periplasm. The two reporters 
allow the detection of protein interactions by growth on selective media, on indicator 
plates or by enzymatic assays. Both MBP and DsbA have been used as fusion partners to 
increase solubility, a feature that can be important for proteins that are susceptible to 
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aggregation. Furthermore, MBP fusions can be easily purified by one-step affinity 
chromatography on amylose resins thus expediting subsequent in vitro analyses of 
protein interactions.    
 Perhaps the most interesting and useful feature of the Tat two-hybrid assay is that 
it takes advantage of the requirement that proteins have to be folded in order to be 
competent for export via the Tat transporter. Neither the detailed mechanism nor the 
features of the folded polypeptide that are interrogated to determine export-competence 
are understood at the moment. However, Fischer et al. (2006) showed that Tat selects for 
proteins exhibiting higher solubility (Fisher et al. 2006). We therefore believe that the Tat 
two-hybrid assay is likely to be useful for reducing false positives that can arise from the 
non-specific interactions or aggregation of non-interacting polypeptides, as well as 
spurious positives arising from properties of a single partner (e.g. inadvertent 
activation/repression of transcription or stress responses that result in a signal).  
During the early steps in their biogenesis, proteins destined for Tat export interact 
with signal sequence specific (e.g. TorD) or general chaperones such as DnaK (Graubner 
et al. 2007; Perez-Rodriguez et al. 2007).   There is no evidence that these cytoplasmic 
chaperones are exported together with their target polypeptide. Consequently, weak 
interactions, such as those between chaperones and their substrates are not likely to be 
detected by the Tat 2-hybrid system. This may not be undesirable for studies aimed at 
finding specific binding partners   The lower limit of protein affinities required to give a 
positive signal has not yet been determined.  
The Tat 2-hybrid is expected to give false negatives, i.e. fail to detect interacting 
proteins, in two instances:  First when the interacting protein partners form a complex 
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which is larger than the size limit that can be accommodated by the Tat pore (<180 kDa). 
Given that the DsbA reporter has a M.W. of 21 kDa this means that the total size of the 
complex formed by the interacting proteins must be less than 160 kDa.  Second, false 
negative may arise when one of the two partner polypeptides exhibits folding kinetics 
that are substantially slower than the typical transit times for Tat export.  When the 
folding kinetics are slow, the off pathway reactions leading to aggregation in the 
cytoplasm predominate and interfere with Tat export (Ribnicky et al. 2007).    
In conclusion, the Tat two-hybrid assay could improve the accuracy of proteome 
wide two-hybrid analyses. In addition, a further useful biotechnological application for 
the Tat two-hybrid system will be in screening of libraries of mutant polypeptides to 
isolate clones that bind to a target protein with increased affinity or to increase solubility 




E. coli tatC mutations that suppress defective twin-arginine transporter 
signal peptides 
 
3.1 INTRODUCTION  
 
The bacterial Twin-Arginine Translocation pathway (Tat) is responsible for the 
transport of cofactor-containing proteins and other folded polypeptides across the 
cytoplasmic membrane.   Proteins exported via Tat contain long signal peptides featuring 
a conserved twin-arginine motif with a consensus sequence of S/T-R-R-x-F-L-K (Berks 
1996).   In Escherichia coli, the functional Tat translocon is composed of the membrane 
proteins TatA, TatB and TatC.  Among Gram-positive bacteria, a few organisms can be 
found containing only two identifiable tat genes, encoding TatA and TatC homologues 
and lacking a tatB gene (Ize et al. 2002; Jongbloed et al. 2002; Pop et al. 2002; Yen et al. 
2002).   In E. coli TatA is purified as a series of high molecular weight homo-oligomers 
that form pore-like structures of varying diameters.  Based on these observations, Gohlke 
et al. (2005) proposed that TatA forms the protein conducting pore that assembles on 
demand, the size of which is determined by the dimensions of the translocated protein 
substrate (Gohlke et al. 2005). Biochemical analyses have revealed that TatB co-purifies 
in a complex with TatC and that this complex plays a key role in the targeting of Tat 
substrates to the translocon (Alami et al. 2003; Dabney-Smith et al. 2006; Gerard and 
Cline 2007). Based on cross-linking of in vitro translocated proteins into inverted 
membrane vesicles, Alami et al. (2003) discovered that TatC in particular exhibits 
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extensive contact with the signal peptide and recognizes the twin-arginine motif (Alami 
et al. 2003).    
We sought to obtain genetic evidence that supports the role of TatC in the 
recognition of the twin-arginine motif and to further define the TatC epitopes that are 
important for this process.   Substitution of the nearly invariant twin-arginine dipeptide 
by two lysines completely abolishes the export of all physiological Tat proteins tested so 
far (Buchanan et al. 2001; DeLisa et al. 2002) .  However, there is evidence for very low 
level export of heterologous proteins such as colicin V(Ize et al. 2002) and the maltose 
binding protein (MBP) when fused to the TorA signal peptide in which the twin arginine 
motif had been mutated to a twin-lysine dipeptide (TorA(KK))(Kreutzenbeck et al. 
2007b).    
 Here we report the isolation and characterization of TatC suppressor mutations 
that allow export of precursor proteins fused to a defective TorA(KK) signal peptide.   
These results provide additional genetic evidence that TatC serves as the receptor for Tat 
signal peptides.  In addition, the suppressor mutations we have obtained help define 
regions in TatC that play a role in the recognition of the twin-arginine motif.   As this 
manuscript was about to be submitted for publication, Freudl and coworkers 
(Kreutzenbeck et al. 2007b) reported the isolation of suppressor mutations in a plasmid 
encoding the TatABCE protein conferring export of a ssTorA-MBP fusions in which the 
RR dipeptide had been substituted by a lysine-glutamine sequence.  Kreutzenbeck et al. 
(2007) presented evidence showing that the suppressor mutations permitted near wild 
type level of export of ssTorA-MBP containing a wild type RR dipeptide.  In contrast, 
mutants we report here appear to represent a different class of suppressors that allow 
export of TorA(KK) signal peptides, but  impair translocation of native Tat proteins.    
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3.2 MATERIAL AND METHODS 
3.2.1 Bacterial strains and plasmids 
Bacterial strains and plasmids are summarized in Table 3.1, their construction is 
described below. 
Table 3.1. Bacterial strains and plasmids 
Strain/plasmid Genotype Reference 
MC4100 F- lacΔU169 araD139 rpsL150 thi flbB5301 deoC7 
ptsF25 relA1 
(Casadaban and Cohen 
1979) 
B1lk0 MC4100, ΔtatC (Bogsch et al. 1998) 
GB22KK-C MC4100, ΔdmsABC::KanR, torA R11K:R12K, 
ΔtatC::SpecR
(Buchanan et al. 2002) 
Xl-1 blue F- thr leu thi lacY galK galT ara fhuA tsx dam dcm 
supE44 
Stratagene 
pTGS sstorA-gfp-ssrA in pBAD33 (DeLisa et al. 2002) 
pKGS sstorA (R11K, R12K)-gfp-ssrA in pBAD33 (DeLisa et al. 2002) 
pBR322-tatC tatC expressed from the tat promoter in pBR322 This study 
pTatC-His8 pBR322-tatC, TatC with a C-terminal octahistidine tag This study 
pTatC-N6 pBR322-tatC, W92G, P97S P172L This study 
pTatC-W10 pBR322-tatC, P142S This study 
pTatC-W10-His8 pTatC-His8, P142S This study 
pTatC-X19 pBR322-tatC, F31S, P67L F75S, F94S,  This study 
pTatC-Y2 pBR322-tatC, S2P, L99P, F124 This study 
pTatC-W92G pBR322-tatC, W92G This study 
pTatC-F94S pBR322-tatC, F94S This study 
pTatC-F94S-His8 pTatC-His8, F94S This study 
pTatC-P97S pBR322-tatC, P97S This study 
pTatC-W92G/P97S pBR322-tatC, W92G, P97S This study 
pTatC-L99P pBR322-tatC, L99P This study 
pTatC-L99P-His8 pTatC-His8, L99P This study 
 
3.2.2 Plasmids construction  
tatC with its own promoter sequence was amplified from pFAT417 (Buchanan et 
al. 2002)  using primers  EMS21 
(GCGGCGGACGTCTCTAGAGGAAGTGCAGCCGCAACTGG) and EMS22 
(GCGGCGCCTGCAGGGTCGACTTATTCTTCAGTTTTTTCGCTTTCTGC) and then 
inserted into pBR322 between the AatII and SalI sites. A 0.6% nucleotide substitution 
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library of tatC was generated by error prone PCR (Fromant et al. 1995) using primers 
TatB2 (Buchanan et al. 2002) and EMS22; the mutagenized gene product was used to 
replace tatC gene in the pBR322-tatC construct. For immunostaining, an octahistidine tag 
was added by PCR amplification with the primers TatB2 and EMS23 
(CGCCGCGTCGACTTAATGGTGATGGTGATGGTGTTCTTCAGTTTTTTCGCTTT
CTGC). Point mutations were generated by site-directed mutagenesis using overlap PCR.  
 
3.2.3 Growth conditions 
All cultures were grown at 37˚C. For genetic manipulations, cells were typically 
grown aerobically in LB media overnight. For SDS growth plate analysis, 1.5% LB agar 
plates were supplemented with 2% SDS and appropriate antibiotics. For anaerobic TorA 
growth selection, cells were grown in closed tubes using Cohen and Rickenberg medium 
(Cohen and Rickenberg 1956) with 0.4% TMAO; glucose was replaced with 0.6% 
glycerol. For TMAO activity gels, cells were grown for 22-24 h in closed 15 ml Falkon 
tubes using Cohen and Rickenberg medium (CR medium) as previously described 
(Sawers et al. 1985) with 0.4% glucose and 0.4% TMAO (Sigma-Aldrich). 
 
3.2.4 Flow cytometry 
Cells were cultivated at 37˚C in LB after subculturing 1/20 from saturated 
overnight cultures. Cultures were induced in mid-logarithmic growth phase with 0.02% 
arabinose, and after a 5 h induction period, cells were washed once with PBS, diluted 100 
times and analyzed by flow cytometry on a BD FACSort™ Cell Sorter or FACSAria.  
Successful sorting gates were set slightly above background (2 fold) based on 
fluorescence at 488 nm/530 nm.  
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3.2.5 Subcellular localization  
15 ml cell cultures were normalized to a total O.D of 5, and then fractionated after 
the osmotic shock protocol (Stanley et al. 2000). Cells were normalized based on OD600 
to a total of OD600 5 and then fractionated by the cold osmotic shock procedure (Stanley 
et al. 2000). Briefly, cells were resuspended in fractionation buffer (30 mM Tris-HCl pH 
8.0, 20% (w/v) sucrose, 1 mM EDTA pH 8.0) incubated at room temperature for 10 min, 
and then after centrifugation re-suspended in ice-cold MgSO4 (5 mM). Spheroplasts were 
sonicated. Debris was removed by centrifugation.  
 
3.2.6 TMAO activity gels 
For TMAO activity gels, cells grown in CR medium with 0.4% glucose were 
fractionated and 12.5% of the obtained fractions were separated by polyacrylamide gel 
electrophoresis (PAGE) under native condition on a 7.5% Tris gel at pH 6.5.  Gels were 
incubated with 20 ml of 100 mM sodium phosphate buffer (pH 7), 1 mM methyl viologen 
was added and reduced by an excess of a 1% dithionite solution in 0.1 mM NaOH. Gels 
were incubated under mildly shaking until stained blue; 10 ml of a 2 M TMAO in the 
same phosphate buffer was added to visualize TorA activity as it can be seen in the 
transparent lanes. 
 
3.2.7 Western blot analysis  
Western blotting was performed as described earlier (Levy et al. 2001). After 
PAGE separation, proteins were transferred to a methanol-activated polyvinylidine 
fluoride (PVDF) membrane (Millipore or Pall Life Sciences) by a semi-dry blotting 
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device (Owl), as recommended by the manufacturer. Membranes were blocked in 5% 
nonfat dry milk/TBST buffer (15 mM Tris-HCl, 4 mM Tris, 137 mM NaCl, 0.1% Tween-
20, to pH 7.6) for 1 hour at room temperature. Anti-His antibodies (Sigma) were applied 
in a 1:5000 dilution in 1% milk PBST buffer overnight at 4°C. Anti-DsbA (1:10 000) and 
anti-GroEL (1:25 000) were incubated in 1% milk TBST for 1 h at room temperature. 
Anti-His antibody was detected with anti-mouse HRP conjugated antibody (BioRad) in a 
1:10 000 dilution whereas the anti-DsbA antibody (Beckwith lab) and the anti-GroEL 
(Sigma) were detected with an anti-rabbit HRP conjugated antibody in a 1:10 000 
dilution with 1% milk TBST. Presence of HRP was detected with the Supersignal® 
Western Pico substrate kit (PIERCE). 
 
 
3.3 RESULTS  
3.3.1 Isolation of suppressor TatC variants by FACS 
 
ssTorA fused to the fluorescent reporter GFP-SsrA allows the facile and 
quantitative detection of Tat export by flow cytometry (DeLisa et al. 2002).  The ssTorA-
GFP-SsrA fusion is encoded by the plasmid pTGS (DeLisa et al. 2002) under the control 
of the arabinose promoter. The presence of the SsrA tag on GFP ensures that any fusion 
protein that fails to be exported via the Tat pathway is degraded by ClpXP (Levchenko et 
al. 2000).  Thus, cell fluorescence arises only from ssTorA-GFP-SsrA that has been 
sequestered away from the proteolytic machinery following Tat-dependent export into the 
periplasmic space (DeLisa et al. 2002; Tullman-Ercek et al. 2007), see Figure 3.1).     
 
Figure 3.1. Schematic analysis of the screen for the isolation of suppressors. 
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E. coli B1lk0 (ΔtatC) (Bogsch et al. 1998) cells carry a complete deletion of the 
tatC gene and therefore exhibit background fluorescence with GFP-SsrA; in addition they 
are sensitive to anionic detergents such as SDS and form filaments. B1lk0 cells were 
transformed with the plasmid pBR322-tatC which encodes the tatC gene with its own 
ribosome binding site downstream of the constitutive tat promoter. B1lk0 pBR322-tatC 
cells also containing pTGS exhibited a 7-fold increase in GFP-SsrA fluorescence, normal 
cell morphology and were resistant to SDS (Figure 3.3 and data not shown).   Mutation of 
the RR dipeptide within  ssTorA-GFP-SsrA to a twin-lysine (KK) sequence reduced the 
cell fluorescence to the background level, but as expected did not have any effect on cell 
morphology or SDS resistance (Figure 3.3 and (DeLisa et al. 2002)).  
The tatC gene was subjected to random mutagenesis by error prone PCR 
(Fromant et al. 1995).    The resulting DNA was ligated into pBR322-tatC in place of the 
w.t. tatC gene.   The ligation product was transformed into XL-1 blue cells (Stratagene) 
resulting in a library of 2x106 independent transformants. The plasmid preparation of 
mutagenized pBR322-tatC was then introduced into E. coli B1lk0 cells transformed with 
a plasmid encoding ssTorA(KK)-GFP-SsrA (pKGS). Sequencing of 6 clones selected at 
random revealed a mutation rate of 0.6% nucleotide substitutions per gene.   
B1lk0 cells expressing the tatC alleles and ssTorA(KK)-GFP-SsrA were then 
screened by flow cytometry and clones with increased fluorescence were isolated. No 
clones with fluorescence comparable to the wild type (around 7-fold higher than 
background) were obtained even after repeated attempts.  However, four clones (B1lk0 
with pTatC-N6, pTatC-W10, pTatC-X19 and pTatC-Y2) that reproducibly exhibited 
about 2-2.5 fold higher fluorescence above background were obtained and studied further 
(see Figure 3.2 for sequence alignment and Figure 3.3 for fluorescence).   
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               10        20        30        40        50          
      ....|....|....|....|....|....|....|....|....|....| 
TatC  MSVEDTQPLITHLIELRKRLLNCIIAVIVIFLCLVYFANDIYHLVSAPLI  
N6    ..................................................  
W10   ..................................................  
X19   ..............................S...................  
Y2    .P................................................  
 
               60        70        80        90       100         
      ....|....|....|....|....|....|....|....|....|....| 
TatC  KQLPQGSTMIATDVASPFFTPIKLTFMVSLILSAPVILYQVWAFIAPALY  
N6    .........................................G....S...  
W10   ..................................................  
X19   ................L........S.................S......  
Y2    ................................................P.  
 
              110       120       130       140       150     
      ....|....|....|....|....|....|....|....|....|....| 
TatC  KHERRLVVPLLVSSSLLFYIGMAFAYFVVFPLAFGFLANTAPEGVQVSTD  
N6    ..................................................  
W10   .........................................S........  
X19   ..................................................  
Y2    .......................Y..........................  
 
              160       170       180       190       200     
      ....|....|....|....|....|....|....|....|....|....| 
TatC  IASYLSFVMALFMAFGVSFEVPVAIVLLCWMGITSPEDLRKKRPYVLVGA  
N6    .....................L............................  
W10   ..................................................  
X19   ..................................................  
Y2    .........S..................R............N........  
 
              210       220       230       240       250     
      ....|....|....|....|....|....|....|....|....|....| 
TatC  FVVGMLLTPPDVFSQTLLAIPMYCLFEIGVFFSRFYVGKGRNREEENDAE  
N6    ..................................................  
W10   ..................................................  
X19   ..................................................  
Y2    ............................C............S........  
 
             
    
TatC  AESEKTEE*  
  ....|.... 
N6    ........*  
W10   ........*  
X19   ........*  
Y2    ........*  
 
Figure 3.2. Sequence alignment of isolated variants. Grey regions indicate predicted 
transmembrane domains after Buchanan et al.(Buchanan et al. 2002) and Ki 
et al.(Ki et al. 2004). 
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The elevated fluorescence phenotype was dependent on the expression of both the 
TatC variant and the ssTorA(KK)-GFP-SsrA reporter protein, suggesting that the 
mutations act as suppressors of the export defect caused by the KK substitution in the 
ssTorA signal peptide.    
With the exception of pTatC-W10, which contained the single amino acids 
substitution P142S, all isolated tatC genes contained multiple amino acid changes.  
Several of the respective single amino acid mutations (W92G, F94S, P97S, L99P, 
A160S, V167D, L172P, C179R and K192N) as well as the double amino acid 
substitution W92G/P97S were generated by site specific mutagenesis and their ability to 
export ssTorA(KK)-GFP-SsrA was analyzed by FACS. TatC carrying the amino acid 
substitutions F94S and L99P conferred cell fluorescence comparable to clones pTatC-
X19 and pTatC-Y2, respectively. The B1lk0 carrying pTatC-N6 contained the amino acid 
substitutions W92G, P97S and P172L. While neither the amino acid change in pTatC-
W92G nor pTatC-P97S displayed export of ssTorA(KK)-GFP-SsrA above background, 
the double substitution variant W92G/P97S exhibited a fluorescence profile comparable 
to that of pTatC-N6 (Fig.3.3.B). None of the other tested single amino acid substitutions 
conferred fluorescence above background in cells co-transformed with pKGS. To 
investigate the effect of mutations on the substrate specificity for the w.t. TorA signal 
peptide, we analyzed the fluorescence of the mutants expressing ssTorA-GFP-SsrA (Fig. 
1.C.). We calculated the relative export efficiency after subtracting the background 
fluorescence of B1lk0 cells transformed with pBR322-tatC and pKGS. The export 
efficiency of the w.t signal peptide fusion for all suppressing variants except for the clone 
carrying pTatC-W10 (containing the single mutation P142S) was around the same 
amount as for ssTorA(KK)-GFP-SsrA, indicating a partial impairment of export.  The 
TatC P142S variant conferred around 65% transport efficiency of ssTorA-GFP-SsrA 





Figure 3.3. Fluorescence histograms of E. coli Blk0 cells expressing either ssTorA-GFP-
SsrA (pTGS) or ssTorA(KK)-GFP-SsrA (pKGS). (A) Cultures were induced 
in mid-logarithmic phase with 0.02% arabinose, and after a 5 h induction 
period, cells were washed once with PBS, diluted 100 times and analyzed by 
flow cytometry on a BD FACSort™ Cell Sorter or FACSAria.  The 
fluorescence histograms of single amino acid suppressors and a 
reconstructed double amino acid substitution exporting ssTorA(KK)-GFP-
SsrA (KGS) are indicated, data shown was acquired by FACSAria. (Gm: 
geometric mean fluorescence, TGS: ssTorA-GFP-SsrA; KGS: ssTorA(KK)-
GFP-SsrA). (B) Average relative export efficiencies of isolated mutants and 
single point mutations exporting ssTorA(KK)-GFP-SsrA and the wildtype 
TorA signal peptide fused to GFP-SsrA. The geometric mean fluorescence 
of the negative control (B1lk0 pBR322-tatC with pKGS) was subtracted and 
the results normalized by comparing the values obtained to the fluorescence 
in B1lk0 pBR322-tatC expressing pTGS. Relative export efficiency was the 
average of three independent measurements from 3 separate cultures for 
each clone; error bars represent the standard deviation of the relative export 
efficiency.  
The level of suppression conferred by the various single amino acid TatC variants 
may also be related to the expression level of the respective proteins.   In pBR322-tatC, 
tatC expression occurs from the weak tat promoter and a pBR322 origin. Attempts to 
detect TatC produced from pBR322-tatC using Western blot analysis with existing 
polyclonal sera (Buchanan et al. 2002; de Leeuw et al. 2002; Punginelli et al. 2007) were 
unsuccessful, evidently because of the low level of tatC expression.  To circumvent this 
problem TatC was fused to an octahistidine tag (His8).  Consistent with previous 
observations we confirmed that a C-terminal His8 fusion does not interfere with the 
function of w.t. TatC or with that of the suppressor variants (data not shown and 
(Buchanan et al. 2002; de Leeuw et al. 2002)).   Western blot analysis of TatC variants in 
total cell lysate revealed that the expression level of pTatC-F94S-His8 and pTatC-W10-
His8 (P142S) was identical to that of w.t. pTatC-His8 expressed whereas pTatC-L99P-
His8 accumulated at somewhat lower levels (Figure 3.4). Thus at least for 2/3 of the 
single amino acid TatC variants, the degree of suppression does not stem from 




Figure 3.4 Western blot analysis of TatC and single amino acid variants. For 
immunodetection of the expression of the tatC single point mutation 
suppressor variants, containing a C-terminal ocathistidine tag. B1lk0 cells 
transformed with the above plasmids were grown in LB media overnight, 
harvested and the same number of cells normalized by O.D.600, were loaded 
(1) pTatC-P142S-His8, (2) pTatC-His8, (3) pTatC-F94S-His8, (4) pTatC-
L99P-His8 expressed in B1lk0. 
3.3.2 Monitoring activity of native TorA enzyme 
Further, we examined whether the putative suppressors identified in the screen 
above could export a native E. coli protein having a twin-lysine substitution in the RR 
dipeptide. The enzyme trimethylamine N-oxide reductase (TorA) reduces trimethylamine 
N-oxide (TMAO) to trimethylamine. TorA contains a bismolybdopterin guanine 
dinucleotide cofactor, which is incorporated into the apo-protein within the cytoplasm, a 
process that requires the chaperone TorD (Pommier et al. 1998; Ilbert et al. 2003).  
Following cofactor incorporation, the TorA holoenzyme is exported into the periplasm by 
the Tat machinery (Santini et al. 1998).   Reduction of TMAO has to occur on the 
periplasmic side of the inner membrane in order to assure electron transfer  from TorC, to 
TorA onto TMAO (Gon et al. 2001).   
In E. coli GB22KK-C (torA R11K,R12K; ΔdmsABC::KanR, ∆tatC::SpecR) the 
twin-arginine dipeptide in the signal peptide of the chromosomal torA gene has been 
replaced with a KK sequence (Buchanan et al. 2001) and there is a complete tatC deletion 
marked with a spectinomycin resistance cassette (Buchanan et al. 2002).  Strain 
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GBKK22-C also lacks dsmABC gene that encodes the only other enzyme that is known to 
reduce TMAO (Buchanan et al. 2001).  The TorA protein in GBKK22-C cannot be 
exported, but it is competent for cofactor assembly and as a result, the active enzyme 
accumulates in the cytoplasm (Buchanan et al. 2001). GBKK22-C cells expressing the 
TatC variants encoded by pTatC-N6, pTatC-W10 (P142S), pTatC-X19, pTatC-Y2,  the 
TatC single amino acid substitution construct pTatC-L99P or the double amino acid 
substitution pTatC-W92G/P97S, were grown anaerobically for 22-24 h in Cohen and 
Rickenberg medium (Cohen and Rickenberg 1956), harvested, and fractionated by the 
osmotic shock procedure(Stanley et al. 2000). The efficiency of the fractionations was 
evaluated by monitoring the level of GroEL and DsbA as cytoplasmic and periplasmic 
markers, respectively. No GroEL could be detected by Western blot analysis in the 
periplasmic fractions whereas DsbA was localized in the periplasmic fraction as expected 
(data not shown). Periplasmic and cytoplasmic proteins were then resolved by native 
electrophoresis and the gel was stained with methyl viologen in the presence of the 
reducing agent dithionite. Reduced methyl viologen served as an artificial electron donor 
for TMAO reductase resulting in a readily detectable color change from blue to 
transparent  upon oxidation of TMAO by the mature TorA enzyme (Silvestro et al. 1988) 
(Figure 3.5).  In E. coli MC4100 cells, about 50% of the active TMAO reductase was 
localized in the periplasmic fraction. No periplasmic TMAO reductase band was detected 
in E. coli GBKK22-C expressing wildtype TatC from pBR322-tatC (Figure 3.5).  
Enzymatically active TMAO reductase, was clearly detected in periplasmic fractions of 
cells co-expressing the TatC suppressors plasmids except for cell with pTatC-W10 
(Figure 3.5).  
 
Figure 3.5. TMAO activity gels. Gels were stained with reduced methyl viologen. 
Reduced methyl viologen serves as artificial electron donor for the reduction 
of TMAO by TMAO reductase, resulting in transparent lanes. MC4100 and 
B1lk0 (∆tatC) containing pBR322-tatC were used as positive controls. 
GB22KK-C cells contain the  a gene encoding TorA(R11K,R12K) in the 
chromosome and the deletion of dmsABC::kan (Buchanan et al. 2002). All 
other variants are indicated. 
 
However, we noticed that cells expressing the plasmid pTatC-W10 carrying the 
tatC P142S allele grew anaerobically with glycerol (0.6%) and TMAO (0.4%) as the final 
electron acceptor. Since periplasmic TMAO reductase activity is required for growth on 
TMAO, TatC P142S variants must be capable of exporting TorA having a KK mutation 




Figure 3.6. Anaerobic growth of GB22KK-C cells expressing the tatC W10 (P142S) 
variant. Non-fermentable glycerol was used as the carbon source, forcing 
the bacterium to utilize TMAO as final electron acceptor. Overnight cultures 
were diluted 1/100 in Cohen and Rickenberg medium (Cohen and 
Rickenberg 1956) with 0.6 % glycerol and 0.4% TMAO (Sigma), and 
grown in  1.5 ml screw cap vials filled to the top and incubated at 37˚C. 
 
Consequently, it is possible that the failure to detect soluble TorA in the 
periplasmic fraction of these cells may be due to the retention of the enzyme on the 
surface of the spheroplasts.  Alternatively it is possible that a very low level of exported 
TMAO that cannot be detected by the assay we used may still be sufficient to allow 






3.3.3 Effects of tatC suppressor alleles on SDS resistance and cell separation  
 
In E. coli, the N-acetylmuramoyl-l-alanine amidases AmiA and AmiC are 
exported by Tat (Ize et al. 2002). These enzymes cleave the peptide moiety of the N-
acetylmuramic acid in peptidoglycan.   Mutations that block the Tat pathway and prevent 
the export of AmiA and AmiC result in sensitivity to SDS (Ize et al. 2002) and partially 
inhibit cell division (Heidrich et al. 2001).  In amiC-deficient strains, the daughter cells 
separate poorly and as a result up to 30% of the population forms chains (Bernhardt and 
de Boer 2003). amiA mutants exhibit a milder defect in septation with only 5-10% of the 
cell population forming short chains. amiA and amiC double mutants show a much more 
pronounced cell chain phenotype than amiC mutants (Heidrich et al. 2001; Bernhardt and 
de Boer 2003; Priyadarshini et al. 2006). Light microscopy of stationary phase cells 
expressing the tatC suppressor genes in B1lk0 (∆tatC) revealed different degrees of cell 
chain formation (Fig 3.7). The TatC P142S variant gave the least defect in cell separation 
with several short chains (3-4 cells) observed in addition to a few single cells. B1lk0 cells 
containing pTatC-N6 showed a higher percentage of longer chains (>4 cells/chain).  The 
TatC W92G/P97S substitutions that recapitulate the cell fluorescence and TMAO activity 
phenotypes of cells carrying pTatC-N6 which contains these two amino acid changes 
next to the substitution P172L, showed a lower percentage of long chains. The TatC 
variants, encoded by pTatC-X19, pTatC-Y2, pTatC-F94S and pTatC-L99P showed 
severe impairment in cell division.  Collectively, this data indicates that none of the 
suppressor mutations completely restored a normal cell morphology suggesting that 
normal Tat export of proteins involved in cell division, presumably AmiA and AmiC, is 
at least partially impaired.     
 
 
Figure 3.7. Morphology of TatC suppressors. Light microscopy photographs of stationary 
phase of B1lk0 transformed with plasmids expressing the indicated tatC 
suppressor alleles. Cells were grown in LB medium at 37˚C. 
 
A functional Tat export system is required for normal cell envelope formation as 
determined by the ability of the cells to grow in the presence of the anionic detergent 
SDS.  W.t. E.  coli cells are almost unaffected by the presence of 2% SDS.  The tatC 
strain B1lk0 fails to form colonies on agar plates with 2% SDS, but upon transformation 
with pBR322-tatC completely restored SDS resistance.  However, cells expressing the 
tatC suppressor alleles failed to form colonies on LB plates with 2% SDS.  The only 
exception was the TatC P142S substitution which showed normal colony formation on 
2% SDS (data not shown). These observations provide further evidence that the TatC 
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suppressor mutations do not support the export of the native Tat proteins which are 




Substitution of the prototypical twin-arginine sequence found in Tat signal 
peptides by a lysine dipeptide  prevents translocation via the Tat pathway in all organisms 
examined so far, presumably because this mutation inhibits the interaction of the signal 
peptide with tatC (Alami et al. 2003).   A search for mutations in the tatC gene that allow 
export of ssTorA(KK)-GFP-SsrA, conferring increased cell fluorescence, ultimately led 
to the isolation of two different types of suppressor tatC alleles having a single amino 
acid substitution each.  Two single amino acid suppressor mutations located on the 
cytoplasmic site of TatC conferred 20-25% of the cell fluorescence relative to the level 
observed with the w.t. tatC regardless of the signal peptide (RR or KK) used. We also 
identified two mutations, W92G and P97S that acted in an epistatic manner to suppress 
the export defect resulting from the substitution of the RR dipetide by KK. Neither of 
these two amino acid substitutions alone conferred export of signal peptides with a KK 
dipeptide. In addition, the two single amino acid suppressors and the W92G/P97S allele 
were shown to confer export of TMAO reductase (TorA) fused to a signal peptide 
containing the KK substitution. Finally, the cells displayed defects in septation and in 
SDS sensitivity.   On the other hand, the amino acid substitution P142S, constitutes a 
different kind of suppressor in that it confers around 15% relative export efficiency for 
ssTorA(KK)-GFP-SsrA, but a significantly higher relative export efficiency of the 
ssTorA-GFP-SsrA (~65%).  This finding and also the cell’s higher resistance to SDS 
suggest that export of Tat substrates containing w.t. signal peptides is not greatly 
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impaired by the TatC P142S mutation.  While we could not detect TMAO activity in the 
periplasmic space of GB22KK-C with the TatC P142S  variant encoded by pTatC-W10 
the finding that these cells can grow anaerobically with TMAO as a final electron 
acceptor, a process that depends on the presence of TMAO reductase in the periplasm, 
revealed that export of the enzyme was taking place.   
The topology of TatC within the membrane has been determined experimentally 
using numerous reporter fusions (Drew et al. 2002; Behrendt et al. 2004; Ki et al. 2004).   
According to this model, the first type of suppressor mutations, F94S, L99P and 
W92G/P97S, are located at the end of the second transmembrane domain and at the 
beginning of the first cytoplasmic loop of TatC, respectively. The first cytoplasmic loop, 
also referred to as the 2nd cytoplasmic domain, of TatC  corresponds to a highly 
conserved region in the bacterial and chloroplast TatC family and it plays a critical role in 
Tat export (Allen et al. 2002; Buchanan et al. 2002). In earlier studies it was reported that 
the mutation L99A severely reduces the export of authentic Tat substrates to less than 
5%. However, the effect of this mutation with respect to KK export had  not been tested 
(Buchanan et al. 2002). Similarly it has been reported that an F94A substitution 
completely abolishes export.   
The mutation P142S is predicted to be located in the second periplasmic loop 
raising the question of how it is able to affect the recognition of  the signal peptide since   
this event is expected to take place, or at least be initiated in, the cytoplasm.  However, in 
a search for tatC mutants that allow export of a defective ssTorA(KQ)-MBP fusion, 
Kreutzenbeck et al. (2007) reported the isolation of the amino acid substitution E8K  
located at the N-terminus of TatB, a domain which is predicted to be localized in the 
periplasm.  The finding that mutations in periplasmic residues in TatC or in TatB can 
impact the recognition of the signal sequence highlights the complexity of the 
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organization of the Tat translocon.   As it has been noted by Kreutzenbeck et al. (2007), 
mutations in residues exposed to the periplasmic side could result in a re-organization of 
the tertiary structure of TatC or TatB. For the thylakoid Tat pathway, signal peptide 
binding was reported to occur in a binding pocket deep inside of the membrane domains 
of the TatB/TatC (Hfc106/cpTatC) receptor complex (Gerard and Cline 2007). Thus, it is 
conceivable that mutations in a periplasmic domain may affect recognition events that 
occur either deep within the membrane or perhaps in proximity of the periplasmic site. 
Alternatively, we cannot rule out the possibility that during the translocation cycle TatB 
and also some domains of TatC may undergo dramatic conformational changes, as it has 
been proposed to be the case for TatA (Gouffi et al. 2004).    
The tatC mutations we identified in the present study exhibit different phenotypes 
relative to those reported recently by Kreutzenbeck et al. (2007).  The latter were isolated 
based on their ability to confer growth of cells expressing ssTorA(KQ)-MBP on maltose 
plates but they were also shown to allow efficient recognition or even higher membrane 
translocation rates of w.t. ssTorA-MBP. We utilized a more stringent screen in which 
export could be quantitatively determined based on cell fluorescence, and isolated 
mutants that suppressed the export defect of ssTorA(KK)-GFP-SsrA.  We found two 
different types of suppressors: One type of suppressor variants exhibited a ~80% 
reduction in the export of ssTorA-GFP-SsrA and also reduced ability to export authentic 
Tat substrates as manifested by septation defects and SDS sensitivity.  These suppressors 
mutations, namely substitutions F94S, L99P and W92G/P97S, are located in the first 
cytoplasmic loop of TatC, unlike the majority of Kreutzenbeck’s mutations, which 
localized within the first few N-terminal residues of the protein.   In addition, we isolated 
the mutation P142S which is located within a putative periplasmic loop and has a more 
moderate effect on the export of authentic substrates, thus leading to SDS resistance but 
partial defects in septation.   
 
 
Figure 3.8. Predicted location of the TatC suppressor mutations. The topological model 
of TatC was obtained from Buchanan et al.(Buchanan et al. 2002), Behrendt 
et al.(Behrendt et al. 2004) and Ki et al.(Ki et al. 2004)  
 
 
The suppressors we characterized in the present study, F94S, L99P, W92G/P97S 
and P142S, lie in the center of the protein sequence at opposite sides of the third 
transmembrane domain (Figure 3.8).  All suppressor mutations resulted in non-
conservative substitutions that are likely to have a significant effect on protein 
conformation.  Interestingly, the TatC single point mutations identified by Kreutzenbeck 
et al. (2007) and the ones reported in the present study were all located within the N-
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terminal half of the protein.   This suggests that the N-terminal of TatC is likely to be 
particularly important for the recognition and interactions with the signal peptide.  In 
agreement with these observations recent in vitro cross-linking studies also highlighted 
the significance of the N-terminus of TatC for signal peptide recognition (Holzapfel et al. 
2007).  
As was the case with the mechanistic elucidation of the Sec export pathway, the 
synergism between genetic and biochemical analysis is expected to lead to deep insights 







Chapter 4  
Studies on the display of GFP variants and randomized GFP selections 
via a Tat-based phage display system 
 
 
4.1 INTRODUCTION  
Antibodies bind tightly and with high specificity to foreign molecules. Their species-
specific core part recruits other modules of the immune response to eliminate the 
intruding molecule or microorganism from the host. It is because of their high specificity 
that antibodies are used for a variety of applications in research. Proteins that bind with 
high specificity are not only useful for diagnostics, but are also of interest for drug 
development and protein purification.  
The green fluorescent protein (GFP) from the jellyfish Aequorea victoria has been widely 
utilized as a reporter for gene expression (Chalfie et al. 1994), protein sorting and 
localization (Kaether and Gerdes 1995; Santini et al. 1998; DeLisa et al. 2002); and it has 
been further used in analyses of organelle shape and mobility (Rizzuto et al. 1995; Cole 
et al. 1996) as well as membrane protein topology (Drew et al. 2002; Drew et al. 2005) 
and to monitor diffusion of proteins within membranes or the lumens of organelles (Cole 
et al. 1996; Subramanian and Meyer 1997). GFP has a β-barrel structure.  The loops 
joining the b-sheets resemble the complementary-determining regions (CDR) of the 
variable loops of antibodies (Figure 4.1.A and B). Hence it is conceivable that the surface 
exposed loops of GFP could provide an analogue to the antigen recognition regions of 
antibodies. The advantage of having a GFP variant with intrinsic binding affinity for a 
protein of interest (POI) is that no invasive technique or detection with substrates or co-
factors will be required to monitor its presence.  An antigen-binding GFP variant 
therefore would be a powerful biosensor that can be further endogenously expressed in a 






Figure 4.1. (A) Loop containing Q157 and K158 marked in red. In blue, residues 190-200 
which can be potentially replaced by a random peptide stretch. (B) M18 
scFv with marked binding loops.   
A variety of display systems are available for the isolation of proteins that bind 
ligands from large combinatorial libraries of protein (Daugherty 2007). By far the most 
commonly used display one is the filamentous phage display technology (Smith 1985). 
However, phage display is dependent on protein secretion through the Sec pathway 
which is incompatible with GFP. When exported via Sec GFP is  translocated into the 
periplasm where it folds into a soluble form, but the chromophore is not established 
(Feilmeier et al. 2000). We therefore decided to utilize a Tat-based phage display 
technology which allows the export of the POI by the Tat pathway (Figure 4.2). Since 
pIII is incompatible with Tat export, it is targeted to the Sec pathway. Association of the 
POI with the pIII anchor protein is mediated by the two adaptor proteins Jun and Fos, one 
of each fused to the POI and pIII (Paschke and Hohne 2005), Tullman-Ercek, 
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unpublished results). A Tat-based phage display has the major advantage that it allows 
the POI to fold in the cytoplasmic environment of the bacterial cell where cytoplasmic 
folding chaperones such as GroEL, ClpB, DnaK/DnaJ/GrpE are available. Translocation 
via Tat further implies that folding proof-reading mechanism is applied to the POI which 
ensures that only correctly folded proteins are exported (DeLisa et al. 2003) and 
displayed. 
 
   
 
Figure 4.2. Tat-based phage display. The protein of interest (POI) fused to Jun and after 
folding in the cytoplasm, it is exported via the Tat pathway. The pIII protein 
is fused to Fos and is exported via the Sec pathway. Association of the POI 
with the anchoring pIII protein is mediated by the interaction of Jun and Fos 
in the periplasm. The interaction of Jun and Fos is stabilized by disulfide 
bridges. The pIII chimera is then anchored into the newly assembled phage.  
The life cycle of the phage is not affected except for the incorporation of a 
chimeric pIII protein. The phage particle associates with the F-pilus of the 
E. coli cell. The single stranded phage genome is inserted into the cytoplasm 
where it recruits bacterial enzymes to assist its replication. The phage 
proteins are translated and its own secretion machinery is assembled which 
allows the secretion of the newly generated phage particle. In this system the 
phage particle has w.t. pIII and chimeric pIII protein, as it is typical for a 





4.2 MATERIAL AND METHODS 
4.2.1 Bacterial strains and plasmid  
For plasmid propagation, cells were typically grown in LB media at 37˚C. For phage 
amplification, cells were grown in 2xYT as described in the methods sections below. 
Plasmids are summarized in Table 4.1 and Figure 4.2. 
 
Table 4.1. Bacterial strains and plasmids 
Name Genotype Source  
DH5α F-(f80dlacZΔM15,) Δ(lacIZYA-argF)U169 
deoR recA1 endA1 hsdR17(rk-,mk+) supE44, 
thi-1 gyrA96, relA1 
Lab strain 
DHF (f80dlacZΔM15,) Δ(lacIZYA-argF)U169 
deoR recA1 endA1 hsdR17(rk-,mk+) supE44, 
thi-1 gyrA96, relA1, (F' proAB, lacIq, lac z 
ΔM15, Tn10 (tetR) 
This study 
MC1061 hsdR2 hsdM+ hsdS+ araD139 Δ(ara-leu)7697 
Δ(lac)X74 galE15 galK16 rpsL mcrA mcrB1 
Lab strain 
TG-1 supE thi-1 Δ(lac-proAB), Δ(mcrB-hsdSM)5 
[F´ traD36 proAB lacIqZΔ M15] 
Lab strain 
Xl-1 blue recA1, endA1, gyrA96, thi, hsdR17, supE44, 
relA1, lac, (F' proAB, lacIq, lac z ΔM15, 
Tn10 (tetR)) 
Stratagene 
pAK400 lac promoter, pUC origin, cmR (Krebber et al. 1997) 









pP-GFPrft-half pAK400, plac sstorA-jun-gfprft(1-157), sspelB-
fos- pIII(198-406),  
This study 
pP-GFPrft pAK400, plac sstorA-jun-gfprft, sspelB-fos- 
pIII(198-406) 
This study 
pP-GFPrft-HPQ pAK400, plac sstorA-jun-gfprft(AGHPQ::157), 
sspelB-fos- pIII(198-406), 
This study 
pP-GFPrft-peptide pAK400, plac sstorA-jun-gfprft(BglII-






Table 4.2 Oligonucleotides  












4.2.2 Library construction 
The N-terminal region encoding amino acids 1-157 of GFP was amplified with the 
primer Gfp-NheI containing NheI cut-site for the 5’ end and the primer Gfprft157rev 
containing the cut-sites BglII, AatII and SphI at the 3’ end. The PCR product was then 
digested with NheI and SphI, and ligated into the plasmid pTJ-PFP (pAK400 containing 
sstorA-jun, sspelB-fos-gIII(198-406), downstream of jun, giving rise to plasmid pP-
GFPrft-half. The C-terminal half of GFP was amplified with the primers Gfprft-158NNB 
and the reverse primer Gfp-SphI with a SphI cutsite. Gfprft-158NNB contains a BglII 
restriction site at the 5’ end followed by 6 random NNB codons (B can be C,G or T) 
before the sequence for the C-terminal half starts (codons for amino acids 158-168). The 
peptide library and the C-terminal half of GFPrft were ligated between the BglII site and 
the SphI site in the plasmid pP-GFPrft-half. 
 




4.2.3 Flow cytometry  
DHF cells harboring the phagemid encoding the GFP peptide insertion variants 
were grown in 50 ml of LB media containing 1% glucose at 37˚C and 25 μg/ml 
chloramphenicol. Upon entry into the mid-logarithmic phase (O.D.600 0.5-0.6), cells were 
transferred into induction medium containing LB with 0.1 mM IPTG and 25 μg/ml 
chloramphenicol. After 3.5 h, 108 cells were washed once in PBS (137 mM NaCl, 2.7 
mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4) and sorted on a Becton Dickinson  
FACSAria flow cytometry instrument (excitation 488/emission 530 nm, fluorescence 
above a geometric mean of 200). Immediately after the first round of sorting, cells were 
sorted a second time, concentrated by filtration and then plated on LB plates containing 
1% glucose and 25 μg/ml chloramphenicol. 
 
4.2.4 Phage amplification  
Cells containing the plasmid pAK400 torA-jun-gfp, pelB-fos-gIII, with or without 
peptide insertion into GFP, were grown in 200 ml 2xYT media containg  1%glucose and 
25 μg/ml chloramphenicol at 37˚C following inoculation to an O.D.600 =0.1. Upon entry 
into the mid-logarithmic phase, cells were infected with M13K07 helper phage in a 1:20 
ratio and incubated at 37˚C without shaking for 1 h. Phage remaining in the supernatant 
was eliminated by centrifugation and re-suspension of the cells in fresh 2xYT medium 
containing the 25 μg/ml chloramphenicol, 0.1 mM IPTG to induce expression and 25 
μg/ml kanamycin to select for cells containing helper phage. After overnight expression 
and phage propagation, phage particles were precipitated using 1/5 volume of 20% PEG, 
2.5 M NaCl, typically overnight or for 4 h at 4˚C. Precipitated phage was resuspended in 
 100
2 ml PBS with 15% glycerol and the titer determined. Typically, titers of around 1012 
colony forming units/ml were achieved. Once the optimum conditions for GFP display on 
the phage were established, cells were typically grown at 30˚C for phage assembly. 
 
4.2.5 Phage panning using immunotubes 
4.2.5.1 Simple coating, simple panning  
 
Immunotubes (Nunc) were coated with the 100 μg/ml antigen while rotating 
overnight at 4˚C.  All following steps were performed at room temperature. Immunotubes 
were blocked with 2% milk in PBS for 2 h while rotating. After 2 wash steps with PBS, 
about 5 x 1011 phage particles (based on cfus) were resuspended in 2% milk PBS, and 
incubated in the immunotubes for 1.5 h while rotating. After another 30 min incubation in 
which the tubes were not rotated, the immunotubes were washed 10 times with PBST 
(PBS, 0.1% tween) and then 10 times with PBS to eliminate weakly bound phage 
particles. For each subsequent round, 5 washing steps for both PBS and PBST washes 
were added. Phage was eluted with 500 μl of 100 mM triethyl amine by rotating for 30 
min. Phage elution was immediately neutralized with 1 ml of 1 M Tris pH 7.4. 700 μl of 
the neutralized, eluted phage solution was used to infect 6 ml of DHF cells in the mid-
logarithmic growth phase. 4 ml of cells were incubated in the immunotubes. Infection 
was performed at 37˚C without shaking for 1 h. 10 μl of infected cells were used for 
serial dilution to determine the total cfus obtained by panning. The remaining cell 
suspension was concentrated by centrifugation and plated on LB plates with 1% glucose 




4.2.5.2 Blocking and preabsorption of immunotubes 
 
For pre-absoprtion, phage particles were incubated in immunotubes that were 
coated with 100 μg/ml glucose oxidase before they were transferred to the tubes coated 
with the antigen of interest.  
Typically, 5 x 1011 cfu of phage displaying the GFPrft peptide library were 
resuspended in PBS containing 2% milk and added to immunotubes which had been 
coated with 100 μg/ml glucose oxidase overnight and blocked for 2 h in the same buffer 
at room temperature. Immunotubes coated with the ligand of interest (100 μg/ml 
lysozyme or transferrin, respectively) were blocked for 2 h with 2% BSA in PBS instead 
of milk to avoid selection of binders to the blocking agent. After 1 h of rotating in the 
pre-absorption tube, the phage solution was transferred into the actual selection tube. The 
panning procedure was performed as described under section 4.2.5.1.  
 
4.2.3 Phagemid panning using magnetic streptavidin beads 
 
4.2.3.1 Pre-absorption step 
 80 μl of the Streptavidin dynabeads stock solution M-280 (Invitrogen) containing 
around 6 x 107 beads were were washed twice with PBS and resuspended in PBS. Beads 
were then blocked for 1 h while rotating. For each step, we altered the blocking agent. 
For odd numbered rounds of panning, beads were blocked with 2% milk whereas the 
phage was resuspended in 2% BSA in PBS. In even-numbered rounds, beads were 
blocked with 2% BSA in PBS and phage was resuspended in 2% milk PBS. Typically, a 
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total number of at least 1010 phage particles (cfus) were used as a starting concentration. 
Phage particles were incubated with blocked beads for 1 h while rotating at room 
temperature. Phage was then used for the following panning procedure.  
 
4.2.3.2 Coating beads with transferrin 
20 μg/ml of biotinylated transferrin (Invitrogen, molecular probes) which contains 
5 biotin molecules per transferrin (as indicated by the manufacturer), was added to 6 x 
107 M-280 beads (pH 7.4). After 30 min incubation of the beads with biotinylated 
transferrin while rotating, beads were washed once and blocked for 1 h with either BSA 
or milk as described under the preincubation step. After 3 wash steps using PBS, phage 
particles from the pre-absorption step were added to the transferring-coated beads and 
incubated for a specific time (see below). 
 
4.2.3.3 Panning procedure 
 
Unless noted differently, all the following steps were performed at room 
temperature while rotating. Phage particles recovered from the pre-absorption step were 
transferred to the transferrin-coated beads and incubated for 1 h; beads were then washed 
3 times with each PBST and PBS to eliminate weak binders. Bound phage particles were 
eluted in 2 steps. For the first elution, beads were incubated for 10 min with 500 ul of 40 
mM triethyl amine; as a second elution step, we used 100 mM triethyl amine (TEA). 
Eluted phage in TEA was immediately neutralized by suspension in 1 ml of 1 M Tris pH 
7.4 buffer. The two different elutes were incubated independently with DHF cells in mid-
logarithmic growth phase and plated. For the second round of panning, recovered 
obtained phagemids was amplified in phage as described above. For the second round of 
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panning, blocking was performed as described above, and two extra wash steps for each 
PBST and PBS were applied to eliminate weak binding phage particles. Further, the 
beads were rotated for an extra 2 h in PBS before elution. Elution was performed as 
described above. After the 1st round, we only amplified phagemid of cells recovered form 
the 2nd elution. However, all recovered phagmid was amplified in phage after the 2nd 
round of panning before proceeding to the 3rd round. Purified phage particles were 
exposed to the 3rd round in which the phage incubation steps with transferrin-displaying 
beads was shortened to 45 min and the washing conditions were intensified: The last 
wash step using PBST was extended to 15 min rotating in PBST, before continuing with 
5 PBS washes. The 4th round was essentially performed as the 3rd round of panning, 
except that the washing step in which the phage particles were rotated in PBST was 
extended to 30 min. 
 
4.2.4 Single clones analysis for fluorescence  
96-well plate overnight cultures of cells grown in 2xYT media containing 1% 
glucose and 25 μg/ml chloramphenicol were subcultured into the same media. After 
growth to mid-logarthmic growth phase (around 2 h), cells were centrifuged and 
resuspended in fresh 2xYT containing 0.1 mM IPTG and 25 μg/ml chloramphenicol. 
After 4 h, cells were washed in PBS and fluorescence was measured using a BioTek plate 
reader (exitation 485nm, emission: 528 nm).  
 
4.2.5 Phage ELISA analysis  
Phage ELISA analysis of individual clones was performed to identify GFP 
variants that bound target selectively. Cells were grown in 96-well plates in 200 μl 2xYT 
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containing 1% glucose and 25 μg/ml chloramphenicol overnight. 20 μl of the overnight 
was used to inoculate 200 μl 2xYT containing 1% glucose and 25 μg/ml 
chloramphenicol. After growth to mid-logarithmic growth phase, cells were infected with 
M13KO7 helper phage in a 1:20 ratio, cell count was estimated on their O.D.600.  After 1 
h of infection at 37˚C without shaking, cells were centrifuged at 4400 xg and resuspended 
in fresh 2xYT medium with 0.1 mM IPTG, 25 μg/ml kanamycin and 25 μg/ml 
chloramphenicol. Phage was produced overnight at 30˚C. 25 μl of the culture supernatant 
was used for ELISA analysis. As control for unspecific binding either laccase, BSA, 
glucose oxidase or streptavidin was used.   
 
4.2.6 ELISA 
Reacti-BindTM White Opaque high-binding plates (PIERCE) were coated overnight with 
100 μg/ml of the ligand (transferrin lysozyme or streptavidin), and either glucose oxidase, 
BSA, streptavidin or laccase as a negative control. After 2 washing steps with PBS, plates 
were blocked with 2% milk PBS for 2 h, washed once with PBST and 3 times with PBS. 
25 μl of culture supernatant were added to 25 μl of 2% milk in PBS, so that each culture 
was tested for binding to the specific antigen and a negative control such as glucose 
oxidase, laccase or streptavidin. After 1.5 h, plates were washed one time with PBST and 
3 times with PBS. Anti M13 antibody (Pharamcia) was applied for 1 h in a 1:5000 
dilution in 2% milk PBS. Unbound antibody was rinsed off by washing 3 times with 




4.3 RESULTS AND DISCUSSION 
4.3.1 Generation of a fluorescent GFP peptide insertion library 
4.3.1.1 Introduction 
The engineering of ligand binding affinities in GFP has been approached by 
several research groups (Zeytun et al. 2003; 2004; Paschke et al. 2007). However, so far 
it has not been possible to insert a diverse repertoire of peptide sequences into fluorescent 
GFP. GFP variants with loop insertions were found to exhibit  low solubility and 
decreased fluorescence (Zeytun et al. 2003; 2004; Paschke et al. 2007). Further, since 
GFP cannot be exported via the Sec pathway in E. coli,  it is not compatible with the 
conventional phage display system (Feilmeier et al. 2000; Zeytun et al. 2004). Surface 
display on yeast could be potentially employed since secreted GFP can assume its 
fluorescent conformation in this organism (Huang and Shusta 2005); however the yeast 
display system is limited by the size of variant libraries that can be screened since 
transformation efficiencies are generally lower than for E. coli.  
Recently, a Tat-based phage display system was developed by the Georgiou lab 
and others (Paschke, 2005; Tullman-Ercek unpublished results).   In our Tat-based phage 
display system, the protein of interest is expressed as a C-terminal fusion to Jun and 
tagged with a Tat signal peptide. After export through the Tat translocon, it associates 
with the Fos-pIII fusion construct which was exported via the Sec system using a PelB 
signal peptide. The heterodimer is then assembled onto the phage particles. In this 
manner, it is possible to generate phage particles displaying fluorescent w.t. GFP or GFP 
mutants.  Here, we describe the optimization of phage displaying fluorescent GFP and the 
generation of a large pool of fluorescence GFP variants containing a sixmer peptide 
insertion.   However, so far it has not been possible to isolate fluorescent GFP variants 
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that bind to ligand, indicating perhaps structural limitations in the repertoire of sequences 
that can be inserted within GFP and still maintain its structural integrity and ability to 
form the chromophore.     
Initially, we tested the GFP FACS-optimized version mut2 (Cormack et al. 1996) 
for its tolerance to a sixmer insertion (AGHPQG) at position 157 (Figure 4.1). The 
fusions ssTorA-Jun-GFP and ssPelB-Fos-pIII were encoded in a bi-cistronic operon in 
the phagemid pAK400 and the peptide was inserted at position 157 by site-directed 
mutagensis. We detected low fluorescence, sensitivity to higher temperatures (37˚C) and 
low phage titers derived from cells expressing GFP with the insertion (data not shown 
and Tullman-Ercek unpublished results). We therefore decided to utilize a more stable 
variant of GFP that affords more efficient folding at 37˚C and better solubility. Further, 
the GFP of choice, GFPrft, fused to the SsrA tag is relatively resistant to the ClpXP 
degradation (Karzai et al. 2000) (data not shown). Briefly, GFPrft14, the parent gene of 
GFPrft were generated by iterative rounds of error-prone PCR/shuffling and screening for 
maximum cell fluorescence (excitation at 360 nm) at 37˚C. The GFPrft14 variant 
contains several mutations that have been isolated in screens for brighter and more stable 
variants such as the cycle 3 variant (Crameri et al. 1996; Siemering et al. 1996) as well as 
the superfolder variant (Pedelacq et al. 2006).  The mutations in GFPrft14 were Q80R, 
E124R, E124V, A154T and V163A. The variant GFPrft14 was further exposed to site-
directed mutagenesis to change F64L and Ser65 into a threonine residue which causes 
more efficient excitation at 488 nm optimizing it for the use of flow cytometry (Patterson 
et al. 1997). The F64L/S65T gave rise to GFPrft (Yasuaki Kawarasaki, unpublished data) 
which we used in the present study.  
In their characterizations of the superfolder GFP variant, Pedelacq and coworkers 
compared the solubility and fluorescence of several circularly permutated GFP variants 
of both the w.t. protein and the engineered superfolder GFP variant (Pedelacq et al. 
2006). Based on their results, it seemed that circular permutation at position 157 allows 
the highest fluorescence and solubility for both w.t. GFP and of the superfolder variant. 
Similar observations were made by Paramban and coworkers (Paramban et al. 2004). 
Therefore, we decided to insert peptides between the amino acids 157 and 158.  
 
4.3.1.2 Fluorescence analyses  
 Cells were grown to mid-logarithmic growth phase at 30˚C and induced with 0.1 
mM IPTG. After a 3 h growth period, uninduced and induced cells were compared via 
FACS on a Becton Dickinson FACSSort instrument. At least at 30˚C, we were able to see 
fluorescence and efficient repression of the protein construct in the absence of the inducer 
(Figure 4.4). Efficient repression is important to avoid any growth disadvantage of clones 
expressing truncated polypeptides that may otherwise overtake the library.    
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Figure 4.4. Fluorescence in TG-1 cells after 3 h induction period at 30˚C. (A) TG-1 cells, 
(B) TG-1 cells with uninduced pAk400 sstor-jun-gfpmut2(HPQ), pelB-fos-
gIII. (C) TG-1 cells harboring pAk400 sstor-jun-gfpmut2(HPQ), pelB-fos-
gIII were induced with 0.1 mM IPTG. 
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4.3.1.3 Optimizing expression and fluorescence of GFP containing peptide insertions  
Since the GFP Mut2 with a peptide insertion showed low levels of fluorescence 
(Tullman-Ercek, Yasuaki Kawarasaki, and unpublished observation) and resulted in low 
phage titers, we proceeded to use the temperature stable GFPrft variant.  In addition we 
switched the host cell to E.coli DH5α which has a slower doubling time and a deletion of 
the recA gene the reduces homologous recombination. Since DH5α does not contain a F-
pilus which is essential for filamentous phage infection, we crossed DH5α with XL-1 
blue (recA1, endA1, gyrA96, thi, hsdR17, supE44, relA1, lac, [F+ proAB, lacIq, lacZ 
ΔM15, Tn(tetR)]) giving rise to E. coli strain DHF. DHF expressing GFP mut2 at 37˚C 
gave substantially higher fluorescence relative to TG-1 cells, but the GFPrft variant 




Figure 4.5. Fluorescence in DHF cells 3 h after induction. Induced cells harboring the 
plamids (A)pP-GFPrft, (B)pP-GFPrft-HPQ  and (C) pP-GFPmut2-HPQ. 
Whereas (B) and (C) are expressing a GFP variant containing a 6aa insertion 
(AGHPQG) at position 157.  
 
We proceeded to generate a peptide insertion library by first engineering a BglII 
site at the codon for aa 157 of GFPrft.  A DNA fragment encoding the  C-terminal half of 
GFPrft with  six NNB codons (B includes all nucleotides but A) at its N-terminus and 
having BglII and SphI sites at the 5’ nd 3’ ends was generated by overlap extension PCR.   
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The PCR product was then ligated within the corresponding sites of the plasmid pP-
GFPrft-half. For transformation of the library, we utilized the E. coli strain MC1061 
which has proven to have high transformation efficiency for ligated plasmid constructs 
due to the deletion of the endonucleases encoded by mcrA/B and hsdR. About 107 
individual clones were obtained and the diversity of the 6-mer insertion was verified by 
sequencing 9 clones selected at random (Figure 4.6). One gfp gene contained an extra 
codon insertion next to the 6 random amino acid codons (not shown). Around 30% stop 
codon are anticipated when using the NNB as a random insertion (Ostermeier 2003).  
 
 
Figure. 4.6. Sequence alignment of peptide insertions from random library variants  
 
4.3.1.4 Enrichment for fluorescent GFP containing peptide insertions 
 
To enrich cells expressing fluorescent GFP variants, cells containing the GFPrft 
peptide library were screened by flow cytometry (FACSAria). The fluorescence 
histogram (ex. 488 nm/em. 530 nm) indicated that 18% of the population was fluorescent 
after a 3.5 h induction period at 37˚C. The sorting gate was set so that cells with 
fluorescence higher than 200 a.u. (a.u.=arbitrary units) were collected.  In addition, a 
forward scatter (FSC) threshold was employed to gate on cells and eliminate debris from 
the sort solution. The forward scatter is directly proportional to the size of cells examined 
by the laser of the flow cytometer. The FSC detector is placed in line with the laser path 
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and the diffracted light is collected. The bigger the cells the more light is scattered and 
the higher the FSC signal. Immediately after the first round of sorting, cells were resorted 
and then plated on LB media with 1% glucose and 25 μg/ml chloramphenicol. 2 x 106 
colonies were obtained reflecting approximately the expected percentage of fluorescent 
variants within the library pool. The overall fluorescence of the selected population was 
around 100 fold above background as detected in a FACSAria instrument (Figure 4.7.A). 





Figure 4.7. (A) Fluorescence histograms of the GFP peptide library, (B) sequence 
alignment of 10 random clones after 2 library sorts. 
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4.3.2 Optimization of GFP display on M13 phage 
 
The enrichment of fluorescent variants of the peptide insertion library was 
performed with cells grown at 37˚C.  However, the conditions for optimum display of 
fluorescent GFPrft on M13 filamentous phage needed to be determined.  Cells harboring 
either pP-GFPrft or pP-GFPrft-HPQ (i.e. containing the 6 aa insertion AGHPQG) were 
grown with or without induction at 30˚C or 37˚C and superinfected with helper phage to 




















Figure 4.8. Fluorescence of M13 phage displaying GFPrft. Different growth conditions 
were tested to optimize display, temperatures are indicated. Phage solutions 
were normalized to 1011 cfu/ml, 200 μl of this solution was analyzed in 
black 96-well plates (Nunc) using a BioTek plate reader (ex. 485 nm/em. 
528 nm). 
In cells that were not induced, GFP expression could not be detected (data not 
shown) and therefore we did not analyze the fluorescence of phage particles amplified 
without an inducer. The phage solution was normalized to a titer of 1011 colony forming 
units (cfu)/ml and 200 μl of purified phage was analyzed for fluorescence (using a 
BioTeck ELISA reader (excitation 485 nm, emission 528 nm) in black plates with 
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transparent bottom (COSTAR®)) (Figure 4.8). Fluorescence of the phage was dependent 
on the temperature at which the phage assembly had occurred. Optimal display of GFPrft 
was achieved when the phage particles were assembled at 30˚C.  Insertion of the 6 aa 
peptide into GFPrf did not reduce the fluorescence of the phage particles 
The fluorescence data shown above might be due to GFP protein that is 
precipitated together with phage rather than intact phage particles.  To rule out this 
possibility we examined whether the phage displayed GFP that could recognized by anti-
GFP antibodies in ELISA assays.   
Phage particles, which were assembled in cells growing at 30˚C, and either 
GFPrft or pGFPrft-HPQ, were coated onto immunoplates by serial dilutions. After 
blocking the wells were reacted with monoclonal anti-GFP antibody and then a secondary 







































































Figure 4.9. ELISA analysis on plates coated in serial dilutions of phage displaying either 
GFPrft or GFPrft-HPQ. Opaque plates were coated with serial dilutions of 
GFP displaying phage. GFP was detected with a monoclonal antibody anti-
GFP antibody which was in turn recognized by a anti-mouse HRP 
conjugate. HRP activity was monitored by chemiluminescence generated by 
the HRP-catalyzed oxidation of Supersignal® Western Pico 
chemiluminescence substrate (PIERCE). Signals were recorded by a BioTek 
plate reader using a 460 nm filter. 
 
The ELISA data indicated that GFPrft is displayed on the phage particle (Figure 
4.9). Surprisingly, the anti-GFP antibody used to detect GFPrft with a peptide insertion 
anchored to the phage reached saturation before the w.t. GFPrft. 
 
4.3.3 Selection for ligand-binding GFP via phage panning 
 
Three different proteins were chosen as possible ligands for panning experiments: 
streptavidin, lysozyme and transferrin. Streptavidin is a 60 kDa tetrameric protein 
isolated from Streptomyces avidinii with high affinity for biotin (10-15 M affinity). The 
14.4 kDa lysozyme hydrolyzes 1,4-beta-linkages between N-acetylmuramic acid and N-
acetyl-D-glucosamine residues which are found in bacterial cell walls. Human transferrin  
is a 80 kDs glycoprotein that binds to its  receptor located in capillary endothelial cells 
and delivers iron from the blood to the brain. Through its interaction with the receptor, 
transferrin crosses the blood-brain barrier via transcytosis. Monoclonal antibodies 
developed to the transferrin receptor are currently used as Trojan horses to deliver 




4.3.3.1 Enrichment for antigen specific binders via immunotubes 
For phage display, ligands can be presented either in soluble form or immobilized 
on beads or immunotubes. Panning steps in which the antigen is presented in a solution 
are considered to be “stringent” and therefore used for the isolation of higher affinity 
binders (Barbas III et al. 2000). In immunotubes, ligands are immobilized and thus 
multivalent binding that results in higher avidity interaction between the phage and the 
immobilized ligand is possible. However, not every antigen binds efficiently to the plastic 
surface of the tubes. Initially, panning relied on immobilization of the ligands to the 
surface of immunotubes. Coating and panning steps are described in detail under the 
method section. The number of colony forming units after each panning step is listed 
Table 4.). Each consecutive round of panning showed a significant enrichment resulting 
in 10 fold or even a 100 fold increase in the number of colony forming units for 
streptavidin, lysozyme or transferrin.  
Table 4.3. Enrichment of phage particles binding to the protein of interest. Numbers 
correspond to colony forming units (cfus). 
Round of panning anti-streptavidin anti-lysozyme anti-transferrin 
1st round 8 x 103 3 x 103 104
2nd round 105 106 106
3rd round 1.3 x 108 5 x 107 N/D 
 
To verify that enrichment was due to the binding of phage onto streptavidin, 



































Figure 4.10. Polyclonal phage ELISA against streptavidin. S2 phage purified after the 2nd 
round of panning. Lib1.2 represents isolated fluorescent GFP variants after 2 
rounds of sorting using FACS. M13K07 is solely helper phage which is not 
displaying any foreign protein. 
Binding of phage displaying GFPrft variants to streptavidin was observed after 
the second round of panning (Figure 4.10). We further performed a third round of 
panning, which resulted in a 1000 fold increase in colony forming units (Table 4.3). 
Individual clones from the second and third round of panning were selected at random. 
72 clones were analyzed for fluorescence in a 96-well plate format (see method section). 
25 clones which gave a fluorescence signal were further analyzed for ligand binding. 
Cells containing the respective phagemids were subcultured and infected with helper 
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phage. After overnight propagation of the phage under conditions in which pP-GFPrft-
peptide variants are expressed, the supernatant was collected, and binding to streptavidin 
was detected by ELISA.  However, only one clone was shown to exhibit binding to 




























Figure 4.11. ELISA analysis of culture supernatant expressing the GFPrft isolate B12S  
Empty phage (M13K07) was used as a control.    
Upon concentration of the phage by precipitation with PEG, clone B12S was 
found to exhibit weak binding to streptavidin that was only about 2-2.5 times higher than 




























Figure 4.12. Phage ELSIA analysis using precipitated phage expressing B12S 
 
Considering the high amount of phage (>109 cfu) needed to detect binding of the 
B12S phage onto streptavidin, it appears that the binding affinity is very low.  The 
difference between the signal obtained with culture supernatants and with purified phage 
may be due to the conditions used for phage precipitation. It is possible that the high salt 
concentration (a total of 0.5 M NaCl) used to precipitate the phage particles disrupted the 
interaction of Jun and Fos. This could result in lower amounts of GFP anchored to the 
phage which would explain the difference between ELISA signals obtained from 
supernatant of the cultures versus purified phage particles. Unfortunately, FACS analysis 
of cells expressing the B12S variant of GFPfrt  revealed that this protein exhibits very 
low fluorescence, only slightly above background (2 fold) compared  to  240 fold about 
background for the GFPrft-HPQ protein (data not shown).  This observation contradicted 
our earlier observation when using 96-well plate fluorescence analysis. FACS analysis 
allows the detection of fluorescence per cell whereas the 96-well plate analysis only 
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measures the overall fluorescence. Cells expressing this variant grew faster which 
increased the overall fluorescence when compared to the other GFPrft variants.  
In summary the above analysis indicates that panning for strepatividin binders 
resulted in the isolation of a weakly binding clone in which the peptide insertion 
interfered with the chromophore maturation of GFP.    
 
4.3.3.3 Panning against lysozyme 
3 rounds of panning against lysozyme coated on immunotubes were performed.  




























Figure 4.13. Polyclonal phage ELISA analyses after different rounds of panning against 
lysozyme. LB1 is the first round of panning, whereas LB3 was the third 
round of panning. L2- and L3--were recovered after panning with pre-
incubation steps (see section 4.3.3.3.1).  
  The ELISA signal decreased after the first round of panning, indicating that non-
binding mutants or possibly truncated versions of GFPrft may have outgrown the binding 
variants during the phage amplification step. Nonetheless, we proceeded to analyze 
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several clones isolated from different rounds. Screening of 25 fluorescent clones (out of 
60 tested) led to the identification of one clone, 5A9L which showed a concentration 


























Figure 4.14. ELISA assays of culture supernatants expressing the GFPrft isolate 5A9L. 
Empty M13K07 was used as a negative control.  
However, similar to the streptavidin binder B12S discussed above, the ELISA 
signal was substantially lower when phage was precipitated with PEG for purification. 
Specifically, the ELISA signal was barely above background binding when compared to 
w.t. helper phage (M13K07) (Figure 4.15). We further detected non-specific binding to 





























Figure 4.15. ELISA analysis using PEG precipitated phage expressing 5A9L and empty 
phage (M13K07) as a control. 
 
4.3.3.3.1 Addition of a pre-absorption step 
Since the panning procedure used above against streptavidin or lysozyme 
enriched only a couple of low affinity binders which seem to be non-specific, we decided 
to alter the panning procedure. Clones recovered after the first round of panning against 
lysozyme were exposed to a pre-absorption step using immunotubes coated with an 
unrelated protein (glucose oxidase). Phage particles displaying the GFPrft variants were 
exposed for 1 h to glucose oxidase-coated tubes before binding to lysozyme coated tubes 
was allowed. Phage elution resulted in 3.5 x 105 cfu. The decrease in colonies compared 
to the second round of panning without preabsorption (Table 4.3), indicated that non-
specific binders were likely reduced from the pool of phage.  We proceeded to perform a 
third round of panning using this protocol, which resulted in an output of 3.6 x 107 cfu. 
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96 clones were selected at random and analyzed by ELISA.  We identified 5 clones that 






















Figure 4.16. Lysozyme binders after 3 rounds of panning in which the last 2 rounds were 
accompanied by a pre-absorption step. ELISA singals were obtained from 
culture supernatant  
However, as seen before, the result could not be reproduced when the phage particles 
displaying the GFPrft variants were concentrated by PEG precipitation.  
 
 121
4.3.3.4 Isolation of GFPrft variants binding to transferrin 
As the polyclonal phage ELSIA indicated, no specific binding clones were 
detected after the first 3 rounds of panning against transferrin. However an elevated 
polyclonal phage ELISA signal was seen with phage particles obtained after the second 































Figure 4.17. Polyclonal phage ELISA against transferrin using purified phage particles 
after the second round of panning. 
We performed monoclonal phage ELISAs on phage isolated after the 2nd and 3rd 
round of panning, but even though 200 different variants were analyzed, we could not 
identify any binders that gave a signal above background. We therefore used the 
population of phage particles after the second round of panning which showed binding to 
transferrin and performed a third round of panning using the preincubation protocol with 
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glucose oxidase-coated tubes. Surprisingly, only 3 x 103 colonies were obtained after 
elution and infection of fresh cells. We analyzed culture supernatants from 200 clones for 
binding to transferrin with laccase or BSA as negative controls.  We identified 10 clones 
that gave slightly higher ELISA signal for transferrin than to the negative control (Figure 
4.16). Differences in the ELISA signals for the negative control are due to different phage 
















Figure 4.18. Phage ELISA on supernatant of infected cells grown in 96-well plates. 
Clones were picked after 3 rounds of panning in which the 3rd round was 
accompanied by a pre-absorption step using immuntubes coated with 
glucose oxidase. 10 out of 192 tested clones showed higher binding affinity 
towards transferrin than towards the negative control.  
All 10 clones which showed higher affinity towards transferrin than glucose 
oxides or laccase (Figure 4.16) were grown in 4 ml cultures, infected with helper phage, 
and precipitated with PEG/NaCl. ELISA analysis using varying phage concentrations 
were performed using transferrin and glucose oxidase as a model unrelated protein. 
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However, all isolates showed higher affinity towards glucose oxidase than transferrin 
(data not shown). 
 
4.3.4 Magnetic bead-based selection for transferrin binding GFP 
 
To circumvent the possibility that transferrin did not bind well to the surface of 
the immunotubes, thus resulting in the negative results discussed above, we used protein 
immobilized on magnetic beads. M-280 Dynabeads (Invitrogen) coated with streptavidin 
were used to pull-down biotinylated transferrin (Invitrogen), which ensures the 
immobilization of transferrin on the beads. However, it also allows binding to the bead 
surface to biotin or to streptavidin. To avoid enrichment to the latter, pre-absorption steps 
were included using blocked beads without transferrin. To further minimize the 
possibility of an enrichment of binders to the blocking agent, we altered the blocking 
solution for each round of panning (see in detail under section 4.3).  
 
4.3.4.1 Panning rounds using the Dynabead system 
As mentioned above a pre-absorption step was performed and the blocking agent 
was altered in each round.  The cfus obtained after each round of panning using the 
dynabead system are summarized in Table 4.4. The increase of the cfus for each round of 
panning indicates enrichment. We further differentiated between phage isolated after the 

















1st round 104 6 x 103 2 x 103
2nd round 2.97 x 
106
1.5 106 105
3rd round N/D 1.12 x 107 7 x 105
 
Polyclonal ELSIA signals confirmed that specific binding of GFPrft displaying 






























Figure 4.19. Polyclonal phage ELISA signals from phage recovered after the indicated 
panning round. Plates were coated with transferrin, phage was added as 
indicated and detected with anti M13 HRP antibody via chemiluminescence.  
4.3.4.2 Single clone ELISA analyses 
 
We tested around 200 colonies from the second round of panning. Binding to 
glucose oxidase and laccase was reduced in general.  We identified several clones with 
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increased binding affinity for transferrin when compared to streptavidin (data not shown 

























Figure 4.20. Positive single clone ELISA showing specificity towards transferrin. Clones 
were obtained from 2nd round of panning using bead approach 
 
However, upon further amplification of the phage carrying the recovered 
phagemid and PEG precipitation, specific binding of the purified phage could not be 
confirmed by ELISA. 
Since we did not identify any transferrin binder in our single clone ELISA screens, the 
question arose whether the phage concentration in the supernatant of the 96-well plates 
was not enough to detect low affinity binders to transferrin. To exclude the possibility 
that too low phage titers were achieved, we performed an ELISA in which we coated 
plates with serial dilutions of supernatant and compared it known phage titers. Phage 
binding was confirmed by the use of anti M13 antibody. ELISA signals indicated that at 
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least half of the 10 analyzed clones had titers around 108 cfu/ml whereas the other half 
contained around 107 cfu/ml (data not shown). Even with low titers such as 107 cfu/ml, 
binding to transferrin should be detected if the affinity had been at least in the 
micromolar range. Hence the lack of an ELISA signal is not due to low phage titers. It is 
plausible that not enough GFPrft was displayed on the phage after precipitation or the 
binding affinities or the binding affinity to transferrin is below 10-6 M.  
 
4.4 CONCLUSION 
We constructed a fluorescent GFP library containing a random sixmer amino acid 
insertion. The theoretical diversity of the sixmer peptide library is 6.4 x 107 individual 
sequences. Our library contained 107 GFP variants clones, 18% out of which were 
fluorescent. We were able to display fluorescent GFPrft containing a peptide insertion on 
filamentous phage particles using Tat mediated export. We further exposed the GFPrft 
library displayed on phage to several rounds of panning against ligands of interest and 
detected binding affinities of polyclonal phage populations. However, we could not 
isolate individual GFPrft variants that exhibited specific binding to lysozyme, 
streptavidin or transferrin.  
 
Previously Paschke et al. reported the insertion of p24 peptide tag into GFP and 
Paramban et al. described the insertion of a 6 histidine residue sequence (Paramban et al. 
2004; Paschke and Hohne 2005). However, both studies demonstrated that the GFP 
variants exhibited decreased fluorescence and low solubility. Our choice of the E. coli 
expression host DHF as well as the usage of the thermostable GFPrft variant as our 
scaffold allowed us to achieve higher cellular fluorescence. Further, this is the first 
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demonstration of the incorporation a peptide library into a functional GFP containing its 
original fold. We established the conditions which allowed the display of completely 
folded and fluorescent GFPrft on a filamentous particle with and without insertions.  
Surprisingly, when we analyzed the fluorescence of phage particles displaying 
either GFPrft or GFPrft containing a sixmer insert, we found that all had a similar 
fluorescence, which is in contrast to the cellular fluorescence measurements by flow 
cytometry. In other words, the difference in the cellular fluorescence level did not seem 
to affect the incorporation of fluorescence GFP into the phage particle under the 
conditions used for phage assembly.  
When phage particles displaying the GFPrft peptide library were subjected to two 
rounds of panning against a ligand of interest, we saw enrichment   evident by an increase 
in the number of phage clones emerging sequential panning steps. We further 
demonstrated concentration-dependent binding of the recombinant polyclonal phage to 
target by ELISA analyses. However, further rounds of panning did not result in the 
enrichment of clones with higher binding affinities, even though more colony forming 
units were recovered. Despite the application of several washing steps, it appears that 
several unspecific phage particles were recovered after each round. If these unspecific 
variants exhibited lower cellular toxicity, their growth advantage over other variants 
would result in an over-representation of non-specific variants in the purified phage 
solution.  
Altogether, we applied 3 different strategies to isolate GFP binders and to 
eliminate unspecific binders. After we were not able to enrich for binders using 
immunotubes and extensive washing, we included pre-absorption steps using 
immunotubes coated with an unrelated protein (glucose oxidase) combined with 
alterations of the blocking agent. Despites these efforts, we could not isolate any specific 
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binder. We therefore utilized a magnetic, streptavidin-coated bead display system for the 
immobilization of biotinylated transferrin combined with pre-absorption steps, changing 
the blocking agent used for each round of panning and increasing the stringency of the 
washing conditions for each round. Again, we still were not successful in isolating any 
ligand-binding GFP variant, even though polyclonal phage ELISA analyses showed low 
binding affinities. We therefore conclude that the binding affinities incorporated into 
GFPrft by a hexameric peptide insertion into the loop at position 157 did not produce 
high enough binding affinities to allow their separation from unspecific binding variants. 
Hence, the inclusion of another peptide sequence into a second loop of GFP could be 
desirable. Alternatively, the binding affinity of the individual phage particle could be 
strengthened by increasing the amount of displayed GFPrft. Our Tat-based phage display 
system was based on a 3+3 phage vector (see Introduction 1.7), which implies that not 
every pIII protein contains a Fos adaptor protein recruit to GFP molecule. The display of 
GFP is further assumed to be low since anchoring to the phage requires first the 
association of the adaptor proteins Jun and Fos, and the formation of disulfide bridges to 
introduce stabilizing covalent bonds between the adaptor molecules. At this time point, 
we are not able to determine the amount of GFP displayed per phage for which we would 
need further analyses. We also detected lower binding affinities of purified phage 
compared to culture supernatant. This could be either due to the effect of high salt used 
for phage precipitation which could interrupt the Jun/Fos adaptor system or the disruption 
of binding of the selected GFP variants to the target ligand. It is conceivable that disulfide 
bridge formation is not efficient enough to allow optimal GFP anchoring, even though the 
presence of disulfide bond was confirmed in both E. coli (data not shown, Tullman-
Ercek, unpublished) and on phage particles (Crameri and Suter 1993; Paschke and Hohne 
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2005). It is possible that an optimization of the disulfide bridge formation step could 
increase the display of GFPrft particularly on precipitated phage.   
 
In summary, we generated a fluorescent GFPrft library displaying 1.8 x 106 
different peptide sequences. We were able to enrich polyclonal phage population that 
showed concentration-dependent binding to the ligand of choice. However, we believe 
that the binding affinities introduced into GFPrft are not high enough to allow the 
identification of single GFPrft variants. A second loop insertion and the change of phage 
vectors could help to achieve this goal.  
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Chapter 5 
Conclusion and future directions 
 
The work described here focused on both the biotechnological applications of the 
twin-arginine transporter pathway as well as the understanding of the basic principles of 
its function.  In the chapter 2 and 4, we describe two applications based on properties of 
the Tat pathway.  In chapter 2 we developed a novel two-hybrid system which takes 
advantage of the inherent proof-reading mechanism of the Tat pathway for the detection 
of interacting proteins. In chapter 4, we sought to develop a Tat-based phage display 
system. The Tat-based phage display system enables proteins requiring folding in the 
cytoplasmic environment to be exported after their folding maturation and to then 
assemble on to the phage. In the 3rd chapter and in the appendix, we listed work aiming to 
understand the underlying molecular basis of the Tat pathway.  In chapter 3, we describe 
the identification of several amino acid substitutions in TatC which allow the export of a 
non-functional signal peptide containing two lysine residues instead of the hallmark twin-
arginine residues that are found in nearly all signal peptides. Suppressor mutations in 
TatC were isolated indicating that this protein is responsible for the recognition of the RR 
sequence in Tat signal peptides. Finally, we described in the appendix two methods to 
detect the topology of TatA, using GFP fusions or the incorporation of a non-canonical 
amino acid containing a chemically reactive group.  
 
 
The new bacterial two-hybrid system for the detection of interacting proteins 
(Chapter 2) capitalizes on the folding quality control mechanism of the Twin Arginine 
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Transporter (Tat) pathway. The Tat export pathway is responsible for the membrane 
translocation of folded proteins, including proteins consisting of more than one 
polypeptide, only one of which contains a signal peptide (“hitchhiker export”). One 
protein (bait) was expressed as a fusion to a Tat signal peptide whereas the second 
protein (prey) was fused to a protein reporter that can conferred a phenotype only after 
export into the bacterial periplasmic space. Since the prey-reporter fusion lacks a signal 
peptide, it can only be exported as a complex with the bait-signal peptide fusion which is 
capable of targeting the Tat translocon. Using maltose-binding protein as a reporter, 
clones expressing interacting proteins can be identified on maltose minimal media or on 
MacConkey plates. In addition, we introduced the use of the cysteine disulfide oxidase 
DsbA as a reporter for Tat mediated export. Export of a signal peptide-prey:bait-DsbA 
complex into the periplasm allowed complementation of dsbA- mutants and restored the 
formation of active alkaline phosphatase, which in turn was detected by a chromogenic 
assay.   
The Tat two-hybrid system can be used as a new tool to identify protein-protein 
interaction on a genomic scale by including two libraries as bait and prey, or it can be 
used to identify protein interaction partners for a protein of interest. Further, the Tat 
pathway can be utilized as a filter for selecting protein variants having higher solubility 
and faster folding. Therefore it should be possible to use the Tat two-hybrid system as a 
genetic screen for the isolation of better folding and solubility of protein pairs while still 
maintaining their binding affinity for each other. This can be a powerful tool for in vivo 
co-evolution of interacting protein pairs. For example, beta lactamase confers resistance 
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to antibiotics containing a beta-lactam ring.  An inhibitor protein of beta-lactamase, BLIP 
(for beta lactamase inhibiting protein), has been identified (Paradkar et al. 1994). 
However, BLIP is highly insoluble and expression in bacteria results in low yields. The 
Tat-based two-hybrid system could be used to optimize the solubility of BLIP while still 
maintaining its binding affinity for beta lactamase. Error prone PCR mutagenesis could 
be applied to isolate more soluble, but functional protein variants of BLIP. Since the 
interaction of beta-lactamase and BLIP has been well characterized, it serves as a 
paradigm for the modeling of protein-protein interactions. It could be interesting to see 
what amino acid bias filtering through the Tat-pathway would introduce, when optimize 
for expression and binding. 
Similarly, several antibodies which are isolated from eukaryotic cell lines such as 
hybridoma cells are often poorly expressed.   The solubility of antibody fragments such 
as a scFv or Fab could be improved by applying the Tat two-hybrid system following 
mutagenesis. This optimization step can also have the advantage that the expression of 
this antibody fragment could be optimized for expression in E. coli which could result in 
significant cost reduction for biotechnological large scale purifications.  
In the forth chapter, we describe the use of a Tat-based phage display system in 
which we optimized the conditions for the display of GFP variants containing a sixmer 
random peptide insertion. We were able to produce 2 x 106 fluorescent GFP variants 
containing a peptide insertion and displayed them on phage particles. We optimized the 
expression of the GFPrft variant for phage incorporation and were able to detect binding 
of polyclonal phage particles to model proteins namely streptavidin, lysozyme and 
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transferrin. However, so far we were not able to identify single clones which would 
specifically bind to the protein of interest. Our analysis indicated that the binding 
affinities might be too low to identify individual clones in our single clone screens. 
Hence, the binding affinities should be increased by inserting an additional peptide 
library into a second loop of GFP. Alternatively, the phage vector could be changed so 
that the linking adaptor protein, Fos, which anchors Jun-GFP to the pIII protein of the 
phage particle would be displayed on every pIII protein. This would allow multiple GFP 
molecules to bind simultaneously, which could increase the affinity of the complete 
phage particle. Further it is possible that the insertion into the loop at position 157 caused 
steric hindrance which prevented specific binding, therefore insertion into a different loop 
could be beneficial. Also by including a certain bias into the peptide insertion, such as 
including the flexible amino acid glycine at the beginning and end of the peptide 
insertion, could further improve the diversity of displayable peptide sequences while still 
allowing a fluorescent fold of GFP. 
 
In the third chapter, we provide genetic evidence for TatC being the protein 
component of the translocon that recognizes the twin-arginine motif within a Tat signal 
peptide.  In vitro studies have suggested that the TatBC complex serves as the receptor 
for signal peptides targeted for export via the Twin-Arginine Translocation (Tat) pathway 
(Alami et al. 2003).  Substitution of the hallmark twin-arginine dipeptide within a Tat 
signal peptide with two lysine residues abrogates export of physiological substrates in all 
organisms.  We isolated and characterized several suppressor mutations that allow export 
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of a ssTor(KK)-GFP-SsrA tripartite fusion. We identified two amino acid suppressor 
mutations in the first cytoplasmic loop of TatC.  In addition, two other amino acids in the 
first cytoplasmic loop exhibit epistatic suppression.  Surprisingly, we also identified a 
suppressor mutation predicted to lie within the second periplasmic loop of TatC, a region 
that is not expected to interact directly with the signal peptide.  The suppressor mutations 
allowed export of the native E. coli Tat substrate TorA with a KK substitution in its 
signal sequence. The cytoplasmic suppressor mutations conferred SDS sensitivity and 
partial filamentation indicating that Tat export of authentic substrates was impaired.   
Having identified only amino acid substitutions within the N-terminal half of 
TatC and knowing that only the N-terminal part is interacting with the signal peptide as 
parallel in vitro cross-linking studies indicated, raises the question how much of the C-
terminal half is essential for Tat functionality. Truncation analyses have been performed 
on TatA and TatB but not on TatC. The bacterium Providencia stuartii contains a TatC 
molecule that contains only the first half of TatC. The complete genome of P. stuartii has 
not been sequenced so far and a possible second homologue could be present. However, 
recent analysis of the Tat pathway in P. stuartii revealed that the deletion of this TatC 
variant abolishes export (Stevenson et al. 2007). The similarity of the N-terminal half of 
the E. coli with the TatC homologue of P. stuartii is 91%, and 75% of the amino acid 
residues are identical. Hence it is conceivable that only the N-terminal half is essential for 
functionality. To approach this question, we generated a truncation library of TatC 
containing 3.5 x 10 variants. When verifying the quality of this library, we identified 
variants of the sizes of 240 bp up to complete length, with the latter being represented by 
5 
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8% of the library which we will analyze for functionality. Growth on SDS medium is a 
simple and fast way to test the functionality of the Tat pathway due to the Tat-dependent 
translocation of the amidases AmiA and AmiC. Therefore, it will be promising to 
investigate into the minimum length of TatC. 
Finally, we describe in the appendix two methods to analyze the topology of 
TatA. Insights into the conformational dynamics of TatA could possibly shed light on the 
mechanism of the actual translocaton step. TatA is the protein component of the Twin-
Arginine Transporter pathway that is most likely mediating the actual translocation step 
of a substrate through the membrane. Its topology however is still disputed. Two 
independent studies claim a dual topology for the C-terminus of TatA. However, they 
contradict each other in the location of the N-terminus which contains the only 
transmembrane domain of the protein. By monitoring GFP fluorescence of TatA-GFP 
fusions and by proteinase K analyses we can confirm the dual topology of the C-terminus 
providing evidence for both cytoplasmic and periplasmic localization.  Further, we 
incorporated the non-canonical amino acid azidohomoalanine in vivo which allowed us to 
incorporate an affinity tag site-specifically into TatA. The newly introduced biotin-PEO 
tag can then be detected by a streptavidin-fluorophore conjugate that was applied from 
the periplasmic site of the cytoplasmic membrane. Using this approach, we confirmed 
that the C-terminal end of the amphipathic helix of TatA is accessible from the 
periplasmic site of the membrane. We demonstrated that the N-terminus of TatA is only 
accessible when Mg(II) is present during the reaction of the azido group of AHA with 
biotin-PEO-propargylamide 
Recently, it was demonstrated that the TatA homologue of Providencia stuartii 
requires a posttranslational modification to be active. Its TatA homologue contains an 8 
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amino acid long N-terminal extension which inactivates the Tat pathway. Proteolytic 
cleavage by the quorum sensing-responsive rhomboid protease, AarA, eliminates the N-
terminal 8 amino acid sequence rendering TatA active. It is remarkable that a short 
extension of TatA controls the functionality of the Tat pathway. There are two possible 
explanations for the inactivation of TatA which would be interesting to analyze. One 
plausible explanation could be that the addition of these extra 8 amino acids prevents the 
oligomerization of TatA with either itself or other protein components of the Tat pathway 
such as TatB or TatC. Another possibility could be that the extension, which introduces a 
strong hydrophilic character with a glutamate-serine-threonine sequence, could impose a 
conformational trap onto TatA. After the negative outside, positive inside rule, the 
transmembrane helix would now be absolutely forced into one topological orientation 
with the N-terminus facing the periplasmic site. This could either result in the inability of 
TatA to oligomerize or simply eliminate its flexibility within the membrane which might 
be required for protein translocation. We therefore think that the two methods described 
in the appendix could be useful to understand the dynamics of TatA by further analyzing 




A.1 Topological dynamics of TatA, mechanistic insights into flipping 
membrane proteins  
 
 
A.1.1 Summary  
TatA is the protein component of the Twin-Arginine Transporter pathway that is 
presumed to mediate the actual translocation step through the membrane. Its topology 
however is still disputed. Two independent studies claim a dual topology for the C-
terminus of TatA. However, they contradict each other regarding the location of the N-
terminus which bears the only transmembrane domain. Here we describe studies to 
evaluate the dual topology of the C-terminus.   We were further able to show that the N-
terminus is accessible from the periplasm in the presence of Magnesium.  
We developed two methods to monitor the topology of TatA: In the first approach 
we utilized a C-terminal GFP fusion. GFP is only fluorescent if it folds in the cytoplasm 
of the cell. We are able to show that the GFP is fluorescent as a TatA fusion, but on the 
other hand it is accessible from the periplasm, as proteinase K studies showed. This 
implies that GFP did fold in the cytoplasm but probably due to the flipping of the 
amphiphatic helix of TatA, localized at the periplasmic site of the cytoplasmic 
membrane. In a second approach, we utilized the site-specific incorporation of a non-
canonical amino acid, the methionine surrogate azidohomoalanine (AHA). Using “click 
chemistry”, AHA was covalently linked to biotin which could be detected by membrane 
impermeable streptavidin linked to a fluorescent dye. We were able to determine the 
location of the N-terminus and the end of the amphipathic helix. This is further the first 
incorporation of an artificial amino acid into cytoplasmic integral membrane protein in 
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vivo. We found that the export of Tat substrates increases the amount of TatA in the 
cytoplasmic membrane and that overexpression of Tat substrate encoded in an inducible 
plasmid saturates the translocon which represses the translocation of indigenously lower 
expressed Tat substrates.  
This project has been performed in collaboration with Dr. A.J. Link. 
 
A.1.2 Introduction 
As summarized by Rapp and coworkers, the orientation of a transmembrane 
domain is simply determined by the charge amino acid residues adjacent to the 
transmembrane domain. Typically negatively charged residues  face an exocytoplasmic 
compartment whereas positively charged residues are located in the cytosol (Rapp et al. 
2007). TatA has one transmembrane domain which has only two positively charged 
residues at the C-terminal site of the α-helix.   The N-terminal site is mainly hydrophobic 
with the exception of one glutamate residue.  TatA can be found in high molecular weight 
oligomers in the cytoplasmic membrane. Electron microscopy studies revealed that TatA 
oligomers form asymmetric pore-like  structures of varying sizes that are large enough to 
accommodate export of various  Tat substrate (Gohlke et al. 2005). Recent NMR analysis 
on the TatA homologue from Bacillus subtilis revealed that the transmembrane domain is 
tilted at a 17˚ angle with respect to the membrane (Muller et al. 2007). 
As mentioned above, the existing topology studies are contradictory.  A total of 6 
different TatA topologies are possible.   Various studies have presented data supporting 4 
of these topologies.  Considering the physiological role of TatA, the fact that it is 
dynamically assembled and that it mediates the translocation of folded proteins of up to 
180 kD in size, it is likely that its conformation requires certain flexibility. The possibility 
that all 6 possible topologies are assumed at some point during the translocation cycle 





Figure A.1. Possible conformation of TatA 
A.1.3 Results 
A.1.3.1 TatA-GFP fusion analyzed by flow cytometry 
Using C-terminal fusions to the reporters  alkaline phosphatase and β- 
glucuronidase, Gouffi and coworker proposed that the  N-terminal of TatA faces the 
periplasm whereas the C-terminus has a dual topology (Gouffi et al. 2004). Chan and 
coworkers however proposed a dual topology with the N-terminus facing the cytoplasm 
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based on analysis of the  accessibility studies using membrane permeable and 
impermeable thio-reactive probes (Chan et al. 2007).  
As was discussed in chapter 1, GFP expressed in E. coli, can only obtain its 
fluorescent fold in the cytoplasmic environment. When exported via the Sec pathway, 
GFP folds within the periplasm, but it is not able to form its chromophore and therefore it 
is non-fluorescent (Feilmeier et al. 2000). This property of GFP was exploited  in a large 
scale study to determine the location of the C-termini of  601 transmembrane proteins 
(Daley et al. 2005). Membrane proteins are integrated into the cytoplasmic membrane via 
the SRP pathway (Luirink et al. 2005) or the Sec independent YidC pathway (Dalbey and 
Kuhn 2004). When fused to the C-terminus of a membrane protein, the fluorescent state 
of GFP is a direct indicator of the location of the C-terminal end of the protein: cell 
fluorescence can only be detected if GFP can fold in the cytoplasm indicating the 
cytoplasmic location of the fusion junction. We generated a fusion of GFP to the C-
terminal of TatA (Figure A.2). The cells were found to be strongly fluorescent. Since 
GFP can only fold in the cytoplasm, the C-terminus must at least temporary be located in 
the cytoplasm so that GFP can assume its fluorescent state (Figure A.3, column 2).  
 
 
Figure A.2 C-terminal GFP fusion to TatA 
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Tat mutant strains are deficient in the export of 2 amidases (AmiA and AmiC), 
which cleave the peptide moiety of the peptidoglycan layer. It is the mislocalization of 
these two substrates which gives rise to the chain-forming phenotype of tat mutants. The 
chain formation can be quantitatively monitored by the forward scatter when using flow 
cytometry. When TatA is not expressed (A.3 column 1 versus 3) the population shifts in 
the forward/sideward scatter (FSC/SSC) profile due to chain formation. However, when 
the TatA-GFP fusion is coexpressed with large amounts of a Tat substrate (ssTorA-
MBP), the FSC/SSC  shows the same behavior as that for  tat deficient strain indicating 
that the overexpressed Tat substrate out-competes the localization of presumably AmiA 
and AmiC (A.3 column 5). However moderate expression of a Tat substrate which solely 
relies on the expression from the leaky trc promoter, allow a different phenotype which 
can be seen as a shift in the FSC/SSC population which shifts towards w.t. cells 
population; at least based on the FSC/SSC profile, cells expressing a Tat substrate at 
lower levels resembled more the w.t. strain (Figure A.1.3 column 4). Further, we noticed 
an increase in fluorescence when co-expressing a Tat substrate which was directly 
proportional to the amount of the substrate expression (comparison Figure A.1.3 column 
4 and 5). The increase of fluorescence could indicate that more TatA is stabilized in the 
cytoplasmic membrane when a Tat substrate is expressed. 
 We further wanted to know whether a high TatA expression level is dependent on 
the expression of other Tat proteins. We analyzed TatA-GFP expression together with the 
Tat substrate ssTorA-MBP in a tatC mutant strain. Surprisingly, when co-expressing 





Figure A.3. GFP fluorescence of TatA-GFP with and without substrate co-expression. 
The first row shows the FSC/SSC profile whereas the second row shows 
GFP fluorescence at ex 488 nm/em 530 nm. Column 1: MC4100 cells, 
column 2 ΔtatA/E cells harboring the induced TatA-GPF fusion in pBAD33, 
column 3: same as column 2 but no induction, column 4: ΔtatA/E cells with 
induced TatA-GFP and uninduced ssTorA-MBP encoded in pTrc99 which 
has leaky expression, column 5: same as column 4, but TorA-MBP is 
induced with 0.1 mM IPTG. 
 
To monitor the functionality of the TatA-GFP fusion in context of translocation of 
the co-expressed ssTorA-MBP fusion, we fractionated cells grown as listed above into 
periplasmic and cytoplasmic fractions and analyzed them by Western blot analysis using 
an anti-MBP antibody which was detected with a anti-mouse HRP conjugate (Figure 





Figure A.4. Fractionation analysis of cells harboring a TatA-GFP fusion with and without 
the ssTorA-MBP substrate expressed. (1) MC4100 ,(2)TatA-GFP(induced), 
(3) TatA-GFP(ind) + pTrc99 empty, (4) TatA-GFP(ind.) + TorA-MBP(ind.), 
(5) TatA-GFP(not ind.) +  TorA(RR)-MBP (ind.), (6) TatA-GFP(ind.) – 
TorA(KK)-MBP (ind.), (7) TatA-GFP(ind.) + TorA-MBP (no ind.), (8) 
TatA-GFP(ind.) + TorA(KK)MBP (no ind.) 
 
A.1.3.2 Proteinase K studies – accessibility of the C-terminus from the periplasm 
Since cells expressing TatA-GFP were fluorescent, we wanted to know whether 
GFP was also accessible from the periplasmic side. Cells cultivated as above, were 
spheroplasted by osmotic shock and lysozyme treatment resulting in the removal of the 
outer membrane and the peptidoglycan layer. We exposed the spheroplasted cells to 300 
μg/ml of proteinase K for 30 min and analyzed them via Western blot analyses (Figure 
A.1.5). As a control for the intactness of the spheroplasts, we monitored the level of the 
cytoplasmic protein GroEL which was unaltered when treated with proteinase K. If the 
spheroplast were lysed, changes in the TatA-GFP proteins could also be due to proteinase 
K cleavage from the cytoplasmic side. As another control, we monitored the GroEL and 
GFP levels of cells that were lysed by treatment with 1% Triton-X. Our data 
demonstrates that GFP can be cleaved-off from the periplasmic side of the inner 
membrane indicating that the GFP does localize on that side of the membrane. When 
analyzing the accessibility of GFP in ΔtatC mutants, we further could confirm the 
cleavage of GFP. (Figure A.5).  This implies that the periplasmic localization of the C-





Figure A.5 proteinase K treatment of spheroplasts 3 h after induction. +/- indicates 
whether proteinase K was applied. (1) MC4100, (2) JARV16 (ΔtatA) 
harboring TatA-GFP, (3) MC4100 with GFP.  
 
 
A.1.3.3 AHA incorporation into TatA, a chemical reaction introduces a new affinity 
tag 
 
Originally, the topology of a membrane protein was assumed to be simple alpha 
helices crossing the membrane perpendicular for several times. Its conformation was 
simply defined based on which part enters and exits the membrane. 60 high-resolution 
membrane protein structures later, this view has changed. Membrane embedded helices 
can be long, short, kinked, half-inserted or crossing the membrane in different angles 
other than 90˚. Also, membrane protein complexes assemble more dynamically and 
spontaneously than assumed. The major disadvantage of currently used, protein-based 
topology markers is that they are bulky and their surface is charged. If fused to a 
membrane segment that localizes within the membrane or is kinked, the properties of the 
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topology marker might force the membrane domain to either site of the membrane, a bias 
which is determined by the properties of the marker protein.  
We tried to circumvent this bias by incorporating the chemically reactive artificial 
amino acid azidohomoalanine (AHA). AHA is incorporated into proteins by exchanging 
methionine in the medium with AHA which causes the cell to charge their methionine 
tRNA with the surrogate. Hence, cells overexpressing the protein of interest in the 
artificial AHA medium incorporate AHA instead of a methionine in a site-specific 
manner. The reactive azido group can then be reacted in a Cu(I) catalyzed step with any 
propagylated ligand of interest. We utilized a triazole ligand together with a 
propargylated biotin containing a PEO spacer to introduce a new affinity tag (Figure 
A.6). The advantange of this approach is that biotin and its spacer are less bulky and 
presumeably less charged than any protein ligand. To identify the location of the 
incorporated biotin, we utilized fluorescently marked phycoerythrin (PE) streptavidin 




Figure A.6. Cu(I) catalyzed click chemistry. Reaction of an azide group with a propargyl 
group catalyzed by Cu(I) in the presence of a triazole ligand. (A) Overview 
of the click reaction, (B) as R1 we used the non-canonical amino acid 
azidohomoalanine, (C) biotin-PEO-propargylamide. 
 
TatA contains a methionine at position 1 and 43. We eliminated the second 
methionine by site-directed mutagenesis giving rise to pTatA-M43L. Cells harboring a 
pBAD24 plasmid containing either TatA or the TatA(M43L) were grown in minimum 
media with and without Mg(II). After growth to the mid-logarithmic phase, the medium 
was switched to the inducing medium containing all amino acids with the exception that 
methionine was exchanged with AHA. Further, the glucose carbon source was exchanged 
with arabinose. After 4 h of growth in the induction media, cells were normalized and 
reacted at 4˚C with 40 μg/ml triazole ligand and an excess of biotin-PEO-propargylamide 
and Cu(I). After a 12 h reaction time, cells were spheroplasted using the same osmotic 
shock/lysozyme treatment as described and incubated with streptavidin-PE at room 
temperature for 1 h. Cells were then analyzed by flow cytometry to see whether 
streptavidin-PE did bind to the surface exposed biotin which was incorporated into the 
TatA variants (Figure A.7). 
 
 
Figure A.7. Flow cytometry analysis of streptavidin-PE (488nm/575nm). Cells grown 
with azidohomoalanine(AHA) and reacted with biotin-PEO-
propargylamide. After spaehroblastin, biotin was detected with streptavidin-
PE. 
To verify that the signal obtained was due to the expression of TatA and not any 
other protein such as beta lactamase which is the antibiotic resistance marker of the 
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plasmid and which localizes in the periplasm, we compared the TatA samples to cells 
containing induced empty plasmid. Our concerns were disproved, since only background 
noise was generated by cells containing the empty plasmid.  
Our data indicates that the N-terminal methionine (or here AHA) was not 
accessible from the periplasmic side when there was no Mg(II) in the click reaction 
solution. However, whenever Mg(II) is depleted in the click reaction, the N-terminal 
AHA cannot be labeled/detected by the streptavidin-PE probe even though it is 
biotinylated  (Figure A.8). To analyze the efficiency of the biotin incorporation and to 
ensure that differences seen where not due to variations in the protein expression levels of 
both TatA and TatA M43L, we performed a western blot analysis using streptavidin 
conjugated to HRP and anti-TatA antibodies detected with anti-rabbit HRP antibodies. 
The western blot result indicates that the Mg(II) addition does not interfere with the click 
reaction since we detected biotinylation (Figure A.8 and data not shown). Therefore it is 
possible that the effect of Mg(II) takes places on a cellular level, possibly affecting the 
ion gradient. Regardless of the N-terminal labeling of TatA we can confirm that the 
methionine at position 43 contributes a strong signal which indicates a periplasmic 




Figure A.8. Western blot analysis of cells grown without Mg(II) with 40 μg/ml AHA and 




A.1.4 Conclusion and future perspective 
In summary we can confirm that the C-terminus of TatA localizes in the 
periplasmic space, but we also demonstrated that the C-terminus is at least temporarily 
located in the cytoplasm since cells expressing the TatA-GFP fusions were fluorescent. It 
will be necessary to monitor how many of the GFP molecules, which were accessible to 
proteinase K, assumed a fluorescent fold.  Together, this data confirmed the flexibility of 
the C-terminal end in respect to its localization. We can further point out that not only the 
C-terminal end of TatA localizes in the periplasm, we also detected that residue 43 of 
TatA is exposed to the periplasm. Residue M43, lies within the end part of the 
amphiphatic helix. By exchanging methionine with AHA, we introduced a biotin residue 
at this position which in turn we detected to be accessible from the periplasmic side as 
shown by labeling with a fluorescent streptavidin-PE probe. We further observed that the 
N-terminal methionine, or in our case AHA, at position 1 can be biotinylated, but it can 
be only detected with a streptavidin-PE probe when there was Mg(II) presence during the 
click reaction. Since the addition of Mg(II) to the reaction mixture did not affect the 
biotinylation, it is likely that Mg(II) affects the ion gradient across the cytoplasmic 
membrane which has consequences on the topology of TatA. We think it will be 
necessary to further test the functionality of TatA containing AHA to ensure that labeling 
and detection happen under physiological conditions. A pulse chase experiment with the 
overexpression of a Tat substrate will be useful to confirm the intactness of TatA 
containing AHA.  
There are several advantages of using a chemical reactive artificial amino acid for 
topology studies. As already mentioned protein reporter fusions are bulky and charged, 
this can pull out the membrane region to either side of the membrane. The amino acid 
composition of periplasmic or cytoplasmic proteins diverges which might have an effect 
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onto which side the membrane domain is pulled. Our biotin-PEO-propargylamide is 
small and less surface-charged than any protein marker, which might circumvent this 
problem. Another advantage is AHA can be fused to an affinity tag, as well as being 
directly linked to fluorophores or a photo-reactive cross-linking agent.  However, since 
currently the possible cross-linking reagent is not commercially available, it would have 
to be synthesized as described by (Hiramatsu et al. 2007). 
Finally, we were able to confirm that the overexpession of a Tat substrate out-
competes the translocation of indigenous Tat substrates. We noticed a shift of FSC/SSC 
towards the same values as a tat deletion strains when expressing ssTorA-MBP from the 
induced trc promoter. However this phenotype was less pronounced when less ssTorA-
MBP was expressed. Also, the more substrate we expressed the higher the fluorescence, 
which indicates that more TatA is stabilized when the translocon is active. Surprisingly, 
we saw the same increase in fluorescence when overexpressing ssTorA-MBP in a ΔtatC 
strain. TatC is essential for the signal peptide recognition. Hence is it conceivable that 
TatA still senses the presence of a Tat substrate without the essential part of the signal 







A.1.5 Material and methods 
 
A.1.5.1 Plasmid construction and bacterial strains 
 
Name  Genotype Source  
MC4100 F- lacΔU169 araD139 rpsL150 thi 
flbB5301 deoC7 ptsF25 relA1 
(Casadaban and Cohen 
1979) 
B1lk0 MC4100, ΔtatC (Bogsch et al. 1998) 
JARV16 MC4100, ΔtatA, ΔtatE  
M15MA M15, ΔmetE (Link et al. 2003) 
M15MAA M15MA, ΔtatA::kanFRT This study 
pBAD33 pACYC origin, pBAD promoter (Guzman et al. 1995) 
pTatA-GFP pBAD33, tatA-tev_cleavage site-gfp This study 
pBAD24 pBR322 origin, pBAD promoter (Guzman et al. 1995) 
pTatA pBAD24 tatA This study 
pTatA-M43L pBAD24 tatA(M43L) This study 
 
A.1.5.2 Growth conditions 
A single colonies were grown overnight in M9 minimal medium supplemented 
with 40 μg/ml of all twenty natural amino acids and 100 μg/ml ampicillin. Cultures were 
subcultured 1/50 into fresh medium. Upon reaching an O.D.600 of 0.5, the cells were 
pelleted, washed twice with M9 salts and resuspended in M9 medium containing AHA 
instead of methionine and all remaining natural amino acids and 0.4% arabinose as a 
carbon source. After 4 h induction cells were harvested by centrifugation and normalized 
to O.D.600 of 0.5.  
 
A.1.5.3 Flow cytometry 
Cells were cultivated at 37˚C in LB after subculturing 1/50 from saturated 
overnight cultures. Cultures were induced in mid-logarithmic growth phase with 0.2% 
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arabinose, and after a 3 h induction period, cells were washed once with PBS, diluted 100 
times and analyzed by flow cytometry on FACSAria.  Successful sorting gates were set 
slightly above background (2 fold) based on fluorescence at 488 nm/530 nm.  
For FACS analysis of the strepatvidin-PE labeling experiments, spheroplast were 




Cultures were normalized to O.D.600 of 2, were washed once in 500 μl  ice cold 
50mM Tris pH 8. After centrifugation, cells were resuspend in 350 μl of 0.75M Sucrose-
100mM Tris (pH 8). 700 μl of ice cold 1mM EDTA (pH 8) were added drop-wise while 
slowly vortexing the tube. 35 μl  of lysozyme (20 mg/ml in 0.75M Sucrose-100 mM Tris, 
pH 8) were added and incubated for 10 min at room temperature. To stabilize the 
spheroplasts, 50 μl of ice cold 0.5 M MgCl2 were added and incubate on ice for 10 min. 
After centrifugation, cells were resuspended in 1 ml PBS (137 mM NaCl, 2.7 mM KCl, 
10 mM Na2HPO4, 2 mM KH2PO4). 
 
A.1.5.5 Proteinase K treatment 
The 1 ml sphaeorblast solution was split into two aliquots of 490 μl each. One 
aliquot was incubated with 5 μl of Proteinase K (Proteinase K stock = 30mg/ml in 50mM 
Tris pH8) on ice, the second one was placed on ice as a negative control. After 1 h of 
incubation, 5 μl phenylmethanesulphonylfluoride (PMSF stock = 33mg/ml in 
isopropanol) were to both aliquots and samples were incubated for further 10 min on ice. 
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Typically 150 μl of treated spaehroblasts were combined with 50 μl SDS loading buffer  
and 22 μl were loaded onto 4%-20% Tris gels.  
 
A.1.5.6 azidohomoalanine and Biotin-PEO-propargylamide synthesis and purification 
Biotin-PEO-propargylamide was prepared by dissolving TFP-PEO-Biotin (Pierce, 
Rockford, IL) in excess neat propargylamine while stiring at room temperature. After 10 
minutes, the solution was added dropwise to ethyl ether. A white precipitate formed and 
was collected by centrifugation. The precipitate was dried.  
Synthesis and purification of AHA from N-α-Boc protected diaminopropionic 
acid was done as described previously (Link et al. 2007b; 2007a) 
 
A.1.5.7 Click reaction and fluorescent labeling 
Cells were normalize to a total O.D.600 of 2 and resuspended in 1 ml PBS (pH 
7.4). About 40 μg triazole ligand was added together with approximately 50 μM of 
biotin-PEO-propargylamide and an excess amount of Cu(I). The concentration of biotin-
PEO-propargylamide represented approximately a 100-fold excess of alkyne to azide. 
The reaction was allowed to proceed for 12-16 h at 4 ºC with agitation. At the conclusion 
of the reaction, the cells were pelleted and spheroplasted as described above.  
200 μl of the spheroplast suspension were exposed to 1000 μg streptavidin-PE for 





A.2 IDENTIFICATION OF NEW TAT SUBSTRATES BASED ON THEIR C-TERMINAL 
ANCHOR SEQUENCE 
 
It seems striking that the five reported membrane-anchored Tat substrates are only 
inserted into the membrane by a short hydrophobic stretch at the C-terminus 
(Hatzixanthis et al. 2003). Most transmembrane proteins have either several 
transmembrane domains or they have a one-domain insertion at the N-terminus. 
Typically these proteins are facing the cytoplasmic side. Further, every protein marked 
for export contains a signal peptide at the N-terminus not at the C-terminus. Based on the 
phenomenon that only Tat substrates contain a C-terminal membrane anchor, the E. coli 
genome was searched for proteins which only contained a short C-terminal hydrophobic 
stretch that would be long enough to insert into the membrane. We utilized an algorithm 
which first determines the possible transmembrane domains of all proteins encoded in E. 
coli using the online transmembrane Hidden Markov model (TMHMM) program; a 
second program was written using Perl, which extracts all proteins containing only one 
transmembrane domain at the C-terminus. The number of proteins identified is 
surprisingly low. As a proof of principle, several Tat substrates out of the originally 
described enzymes were identified. We only report proteins longer than 100 amino acids 
(summary in Table A1). Possible functions were assigned based on BLAST and Smith-






















ybjT 486 470 putative oxidoreductasea
flk 331 330 flagellar assembly protein 
ygaM 113 110 putative inner membrane proteina  
ygdL 268 257 putative enzyme, NAD(P)-bindinga
hybOb 372 354  
ygiM 206 195 arylsulfatase inVibrio fischeri ES114a
rfaJ 338 332 UDP-D-glucose:(galactosyl)lipopolysaccharide glucosyltransferase 
nrfFc 127 121 part of formate-dependent nitrite reductasea
fdnHb 294 279  
ybeS 475 473 
putative enzyme of polynucleotide modification; putative chaperone (J-
protein like) 
 
b: has been already identified as a Tat substrate 
c: Tat substrate not further analyzed in respect of the export 
a: seemed to be interesting functions  
 
The proteins ybjT, ygdL, rfaJ, ybeS were of particular interest since they do not 
contain signal peptides and seem to either associated with a membrane or redox 
cofactors. The fact that they were missing a signal peptide was especially interesting, 
since if they are Tat substrates, they would require to use the hitchhiker mechanism 
through the Tat pore.  
Proteinase K studies, performed as described under section A.1, confirmed that 
YgdL and YbjT face the periplasmic side of the membrane whereas YgaM is not 
accessible from the periplasmic side. Further analysis would be necessary to determine 
their Tat dependency.  
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A.3 A NEGATIVE GENETIC SCREEN FOR THE IDENTIFICATION OF FACTORS 
INVOLVED IN TAT EXPORT 
Objective: identification of proteins that promote Tat export.  
Introduction: The chloramphenicol resistance is transferred to a bacterium by the gene 
encoding chlorampenicol acetyl transferase (CAT). CAT transfers an acetyl-CoA unit 
onto chloramphenicol which results in resistance to this antibiotic. Since acetyl-CoA is 
only available in the cytoplasm, cat is only functional in this subcellular localization. 
Hence, fusion of the cat gene to a Tat signal peptide provides a genetic screen for a loss-
of-function (Hicks et al. 2005).  
Results: We generated a transposon library in MC4100 (2 x 105) which we screened with 
a ssTat-Cat reporter fusion for growth on chloramphenicol plate. If this construct is 
exported, the cell cannot grow. To avoid the isolation of insertions into any of the tat 
genes, we expressed the complete tat operon from a second plasmid. Transposon 
insertion into MurD, a UDP-N-acetylmuramoylalanine-D-glutamate ligase, which 
catalyzes the addition of the second amino acid to the peptide moiety of the monomer 
unit of peptidoglycan was pulled out several times. However, this is most likely not 
related to the Tat pathway since this enzyme localizes on the periplasmic side of the 
membrane and would hardly be able to promote Tat mediated export. It seems plausible 
that deletion would confer a higher resistance to chloramphenicol by either changing the 
properties of the peptidoglycan in a way that less chloramphenicol could enter the cell or 
by including chloramphenicol into the peptidoglcyan biogenesis pathway to compensate 
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